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Interest in the use of DNA nanotechnology in biomedical applications has increased 
tremendously in the last decade due to the uniqueness of DNA properties that allow precise and 
predictable construction of synthetic DNA building blocks, which later form higher complex 
DNA structures. Moreover, the synthetic DNA structures can be manipulated by the same 
molecular toolkits as natural DNA and naturally degraded to metabolite by-products. Thus far, 
most of the biomedical applications employing DNA nanomaterials are related to gene delivery 
and detection due to Watson-Crick base pairing rules. For example, the DNA nanostructures 
have been used in detecting DNA and RNA in biological systems by an innate hybridization 
property between the DNA nanostructures and target oligonucleotides. Moreover, the DNA 
nanostructures have been used as a carrier for antisense DNA or siRNA. Here, we present the use 
of synthetic branched DNA nanomaterials for a co-delivery of Doxorubicin and siRNA and a 
hydrogel-based scaffold for 3D cell culture. First, we demonstrate the development of the novel 
DNA-lipid co-delivery nanocarriers called DNAsomes. The DNAsomes can be loaded with both 
siRNA and hydrophobic drugs that promote synergistic effects. The DNAsomes exhibit lower 
doses of drugs required for therapy. Furthermore, we propose a novel DNA hydrogel-based 
scaffold for 3D cell culture. Cells grow, proliferate, and form multicellular spheroids (MCS) 
inside the DNA hydrogels. The DNA hydrogels are naturally degraded by effects of FBS in the 
culture media and by-products secreted from the cells. In addition, the DNA hydrogels can be 
degraded on-demand by a DNase I enzymatic reaction to release cultured MCS without any 
disruption to the MCS. Also, re-encapsulation of released MCS is possible allowing several 
 downstream applications of the MCS. Lastly, we demonstrate the potential use of DNA 
hydrogels for 3D siRNA delivery. The siRNA hybridize to the DNA building blocks forming 
siRNA hydrogels. The time-specific release of siRNA can occur in the presence of RNase H only 
degrading RNA/DNA hybrids bridging the DNA hydrogels and siRNA. By adding different 
amount of RNase H, the siRNA controlled release profiles are different. The siRNA hydrogels 
can potentially be used to culture and transfect the MCS at the same time. 
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CHAPTER 1 
Introduction 
In this dissertation, I focus on developing new platforms utilizing synthetic branched DNA-based 
nanomaterials for drug delivery and three-dimensional (3D) cell culture. First, I introduce the 
generic properties of nucleic acids, both DNA and RNA, which rendering a number of 
advantages for biomedical application. Then, I demonstrate the co-delivery system of small 
drugs and small interfering RNA molecules (siRNA) by exploiting novel branched DNA-lipid 
amphiphile building blocks that self-assemble to liposome-like DNAsomes. Next, I purpose a 
new 3D cell culture hydrogel-based platform using the synthetic DNA hydrogels. The novel 
DNA hydrogel-based scaffold can be both naturally or on-demand degraded allowing retrieval of 
encapsulated multicellular spheroids without mechanical and chemical disruption of the 
spheroids. I then propose another biomedical application by employing the synthetic DNA 
hydrogels as a siRNA-controlled release reservoir by taking advantages of nucleic acid inherent 
properties in naturally hybridizing between DNA and siRNA molecules. The siRNA molecules 
are released and controlled by the presence of RNase H enzymes. Last but not least, I propose 
the combined two-in-one DNA hydrogel-based scaffold for 3D cell culture and siRNA delivery.  
 
1.1 The fundamental generic properties of nucleic acids 
Soon after the discovery the structure of deoxyribonucleic acid (DNA) by Watson and Crick in 
1953, further investigations of physical and chemical properties, and organization of nucleic 
acids at nanoscale levels have been revealed and become useful for nanotechnology (1-3). These 
extensive studies of the nucleic acid structures include not only DNA structures, but also 
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ribonucleic acid (RNA) structures that were elucidated a few years after the discovery of the 
DNA structures.   
1.1.1 DNA  
The first appearance of the molecular structure of deoxyribonucleic acid (DNA) was revealed by 
Watson and Crick in 1953 (1), a finding that has catalyzed a growing field of research on DNA.. 
In total, three main species of DNA consisting of A-, B-, and Z- conformations (4, 5) have been 
discovered. Each conformation of DNA is reversible and governed by a number of 
environmental factors. These include for example, pH, which is a degree of hydration, a 
concentration of metal ions, and the presence of polyamines (6-10). The B-DNA structure is the 
most common DNA structure found under physiological conditions and widely used in several 
biomedical applications. Thus, the B-DNA structure will be employed as a DNA structural 
model and simply referred to as DNA structures throughout this dissertation. The DNA structure 
consists of two deoxyribonucleotide chains non-covalently held together by two major forces. 
The first force is a non-covalent hydrogen bond between nucleobases of the two 
deoxyribonucleotide chains. Second, a van der Waals interaction holds stacking aromatic rings of 
nucleobases (2, 11). Each of the deoxyribonucleotide chain is comprised of nucleotide subunits 
where the components include a pentose 2’deoxy pentose sugar ring, phosphate group, and 
nucleobase. Each of the nucleotide subunit connects to each other by a phosphodiester bond 
between the 3’ hydroxyl groups of one nucleotide and the 5’ phosphate groups of an adjacent 
nucleotide. Specifically, the double-stranded deoxyoligonucleotides form a double helix 
structure in an anti-parallel direction (5’ to 3’ direction) generating major and minor grooves 
alternatively along the double-stranded DNA structures (2). The pentose sugar ring links to the 
phosphate group at the 5’ position and to one of four nucleobases at the 1’ position. The four 
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nucleobases for DNA include adenine (A), guanine (G), cytosine (C), and thymine (T). All four 
nucleobases have specific interactions and follow Watson-Crick base-pairing rule: A only pairs 
with T and C only pairs with G by hydrogen bonds. The diameter throughout the DNA structures 
is about 2 nanometers (nm), rendering a defined geometry for the DNA structures. The length of 
DNA structures can be varied from a few nm to sub-centimeters (cm) in nature (12). Hence, the 
DNA molecules are considered to have high aspect ratios (small diameter and long length). As 
the diameter is constant throughout the structures, the stiffness of any DNA structures are 
determined by their lengths. The DNA structure of which the length is less than a persistence 
length (~ 50 nm) behaves as a rigid molecule (3, 13). Longer lengths of DNA structures become 
more flexible and tend to coil into supercoiling structures. However, the persistence length can 
be reduced to 1-2 nm in single-stranded DNA in order to add flexibility to the structures (14).   
1.1.2 RNA 
A structure of RNA is similar to that of DNA such that it also contains a pentose sugar ring, 
phosphate group, and nucleobases. However, two distinct differences exist between DNA and 
RNA along the type of pentose sugar rings and regarding one of four nucleobases. The pentose 
sugar ring at the 2’ position of RNA contains a hydroxyl group while that of DNA is replaced by 
a hydrogen atom. Besides, a thymidine nucleobase (T) in DNA is replaced by a uridine 
nucleobase (U) in RNA. Another important distinction between DNA and RNA is that DNA 
naturally exists in a double-stranded form whereas RNA is usually exists in a single-stranded 
form. The single-stranded RNA can also form complicated secondary structures due to the extra 
hydroxyl groups on the sugar ribose rings, thereby increasing the opportunity to form hydrogel 
bonds.  Occasionally, under physiological conditions, RNA appears in double helices in an A-
form structure , unlike DNA, due to the presence of an extra 2’ hydroxyl group on the pentose 
4 
 
sugar rings, which prevents the RNA to have a B-form configuration (15). As for the dimensions 
of RNA, it has been shown that the duplex RNA is stiffer than DNA. Depending on 
measurement techniques, the persistence length of double-stranded RNA ranges from 60 to70 
nm (16, 17). 
 
1.2 Nucleic acid building blocks for nanotechnology 
Based on the fundamental properties of the nucleic acids, several of these properties have been 
utilized in constructing nanostructures and broadly used in many nanotechnology applications 
(13). First of all, nucleic acid structures are well-characterized in components and molecular 
organization, which thereby allows one to predict, modify, and tailor physical and chemical 
properties for specific uses (18). Secondly, the formation of the double helix structures is 
precisely controlled by the sequences and governed by the Watson and Crick base-pairing rules. 
Consequently, the precisely designed double-helix nucleic acid structures can form a number of 
complex and high-ordered nucleic acid nanostructures that can also be manipulated by several 
molecular toolkits. In addition, the source for obtaining nucleic acids is straight-forward, 
allowing production to occur in bulk scale (million copies) from both natural and artificial 
sources. For example, large circular plasmids can be extracted from recombinant bacteria that 
can produce as high as a milligram scale of DNA in one extraction process. Synthetically, DNA 
can be produced from solid phase reactions yielding DNA up to a milligram scale as well. More 
details about obtaining nucleic acids are discussed later in this chapter. In order to thoroughly 
exploit and manipulate nucleic acids as the building blocks of nanostructures for desired uses, 
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four key features, which are sources of nucleic acids hybridization, chemical stability and 
modification, and molecular toolkits—are emphasized in the following section. 
1.2.1 Sources of nucleic acids  
1.2.1.1 DNA 
By taking advantage of the DNA self-replication mechanism of small organisms, a large scale of 
pre-designed DNA can be produced with high fidelity of corrected inserted sequences based on 
enzymatic proof-reading properties (19-22). One of the most ground-breaking research used the 
circular genomic DNA obtained from the virus M13mp18 to self-assemble into complex DNA 
nanostructures (22). Additionally, DNA can be synthetically generated by chemical and 
enzymatic reactions. For chemical DNA synthesis, DNA is generated by using solid phase 
reaction, which allows for an opportunity to freely design the sequences of DNA. However, the 
solid phase synthesis has limits; such that only short DNA up to about 100 bases can be 
generated. An enzymatic DNA synthesis, on the other hand, can facilitate DNA production up to 
several kilobases (kbs). A general technique to enzymatically produce long double-stranded 
DNA is called polymerase chain reaction (PCR). The PCR reaction mimics the cellular DNA 
replication machinery and depends on DNA polymerase enzyme activity. Rolling-circle 
amplification (RCA) reaction was also reported to replicate long single-stranded DNA that 
thermodynamically folds to form four-armed DNA nanojunctions by stapling with five 
additional short single-stranded oligonucleotides (23). 
1.2.1.2 RNA 
A variety of natural RNA carries multiple biological functions (24, 25). These RNA can be 
classified based on cellular functions such as ribosomal RNA (rRNA), messenger RNA (mRNA), 
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transfer RNA (tRNA), micro RNA (miRNA), and non-classified RNA. In its natural form, RNA 
is available in a single strand, transcribed from the antisense DNA strands. As a result, a number 
of RNA transcripts can interact among bases on their own strands and form secondary structures. 
In nanotechnology, these RNA sencondary structures can potentially serve as jointing molecules 
between nucleic acid nanostructures due to the flexibility of the single-stranded forms. However, 
natural RNA is naturally more prone to degradation than DNA owing to RNA’s additional 2’ 
hydroxyl groups, which are sensitive to alkali hydrolysis. Hence, using naturally-occurring RNA 
as a part of nanostructures can be problematic unless RNA is modified to endure extreme 
conditions.  
Like DNA, RNA can be artificially synthesized with designed sequence specific foled RNA 
nanostructures. An artificial RNA synthesis can be obtained by either a chemical synthesis or an 
in vitro enzymatic transcriptional approach. The chemically synthesized approach is superior to 
the enzymatic approach as modified backbones, sugars, and bases that cannot be processed by 
biological enzymatic reactions can be incorporated to the synthesized RNA stranded. However, 
current commercial synthesis limits the length of RNA from the chemical synthesis to about 100 
nucleotides due to complications in the synthesis process (26). On the contrary, the enzymatic 
approach, which relies on in vitro transcription mechanism of RNA polymerase enzymes, offers 
the synthetic RNA production up to several kbs. Unfortunately, these long RNA generated from 
the enzymatic reaction suffers from errors in base proof-reading mechanisms. Also, the 
modification of RNA in the enzymatic reaction is limited due to the low affinity and efficiency 
of the RNA polymerases to modified incorporated nucleoside monophosphates (27).  
A plethora of sources from which to obtain both DNA and RNA for self-assembling nucleic 
acid nanostructures exist. Depending on product sizes, purposes, and applications, a suitable 
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method to obtain nucleic acids can be chosen.   
1.2.2 Hybridization 
As briefly detailed above, two single-stranded polynucleotides self-associate, or hybridize, via 
non-covalently hydrogen bonding interactions following Watson-Crick based-paring rules (2). 
Nucleobases A and G are double-ring pyrine bases (R) while C, T, and U are single-ring 
pyrimidine bases (Y). According to Watson-Crick base paring rules for nucleic acids, A and G 
hybridize to T (U) and C, respectively. Watson-Crick base-pairing rules are simple, yet 
tremendously useful for constructing any nucleic acid-based nanomaterials. The high fidelity and 
affinity of the base-pairing result in a precise structure formation. Also, hybridization render the 
benefit of joining two nucleic acid nanostructures by overhang sequences without any physical 
and chemical reactions. The overhang at the end of the nucleic acid structures hybridize to a pre-
designed complementary overhang of the other structures, thereby generating the combined 
structures.  By designing the complementary sequences and thermostability of the overhangs 
between two nucleic acid structures, higher-ordered structures of nanostructures can be self-
assembled in a programmable fashion (18). 
1.2.3 Chemical stability and modification of nucleic acids 
Two major covalent bonds involved in both DNA and RNA structures are 3’-5’ phosphodiester 
and N-glycosidic bonds linking between two adjacent sugar rings and a sugar ring to a 
nucleobase, respectively. Both of the covalent bonds are mainly susceptible to hydrolysis and 
oxidation reactions at different degrees depending on  endogenous (primary structures, bases, 
and sugars) and exogenous parameters such as pH, metal ion, buffer (28). For example, RNA is 
more susceptible to hydrolysis in alkali environment than DNA because the 2’ hydroxyl group 
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on the ribose sugar is deprotonated leading to a cleavage of the phosphodiester bond (28). On the 
contrary, the 2’OH group of the RNA renders an inductive effect causing its N-glycosidic bond 
to be more stable than DNA, which results in enhancing the stability of the phosphodister bond 
(29). For oxidation, the reactions involve reactive oxygen species (ROS) mainly generated by 
photolysis and ionizing irradiation of oxygen-containing molecules (30). The ROS are such as 
hydrogen peroxide, hydroxyl radical and super oxide. In general, the ROS can interact with all 
components of nucleotides. The most susceptible component is an aromatic ring of nucleobases 
as they are rich in electron clouds (31, 32). Additionally, the nucleic acid stability comprises a 
major issue in biomedical fields as nucleic acids undergo fast degradation in the presence of 
nuclease enzymes that are naturally found in vivo. To enhance the stability of nucleic acids, a 
number of modification methods have been reported and aim at modifying all three nucleic acid 
components consisting of a phosphate group, a sugar ring, and four nucleobases (27, 33).  
To begin with, the phosphate group can be replaced by several chemical groups that are not 
subject to intracellular nuclease substrates to avoid degradation (33). The short strand of 
phosphate group-modified oligonucleotides can be conveniently achieved by solid-phase 
chemical synthesis (27). One of the most conventional phosphate group replacements is to 
displace a non-bridging oxygen atom with a sulfur atom, thereby creating a phosphothioate 
group (PS) and making the modified oligonucleotides less susceptible to nucleases by 10- to100-
fold (34). The PS oligonucleotides have been widely used in antisense oligonucleotide drug 
delivery systems (35-37). In addition to the sulfur atom, the oxygen atom can also be replaced by 
amine or borane groups producing phosphoramidite and boranophosphate oligonucleotides, 
respectively (38-40). Alternatively, the whole phosphodiester backbone can be replaced by a 
synthetic peptide backbone rendering a nucleic acid analog called peptide nucleic acid (PNA) 
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(41). The hybridized structures of PNA to DNA and/or RNA tremendously increase thermal 
stability and exhibit unique ionic strength properties (42-45).   
The pentose sugar ring modification can be achieved by enzymatic reactions utilizing either 
DNA or RNA polymerases. Limited non-natural nucleoside triphosphates can be incorporated 
into newly synthesized oligonucleotides based on wild-type polymerase enzyme affinities (27). 
Some of non-natural 2’ deoxynucleoside triphosphates such as 2’ O-methyl-, 2’ amino, and 2’ 
fluoro-nucleoside triphosphates can be processed with low efficiency by T7 RNA polymerases 
(46-49). Attaining a higher incorporation efficiency of the modified nucleoside triphosphate was 
achieved by utilizing tyrosine-mutated T7 RNA polymerases (50, 51). These 2’ deoxynucleoside 
triphosphate modifications are widely used in nuclease resistance applications (52-54). In 
additional to the 2’ deoxy-nucleoside modification, 4’ C-position has also been modified by a 
methylene and sulfur group to investigate the effects of polymerase activities to nucleoside 
analogs (55, 56).  
For nucleobases, several positions on purine and pyrimidine bases have been substituted in 
nucleic acid modifications. Nevertheless, the modification at the positions responsible for 
hydrogen bond formation can destabilize or demolish a double-helix structure. Thus, general 
nucleobase modifications are most generally employed for studying contacts between the base-
pairing of the nucleic acid structures. Examples of positions involved in the nucleobase 
modification include7’ N-, 3’ N-, and 1’ N-positions on purine bases (57-59) and 2’, 4’, and 5’ 
positions on pyrimidine nucleobases (60-62).   
 
1.2.4 Molecular toolkits for engineering nucleic acid nanostructures 
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Nucleic acid nanostructures can be manipulated by molecular biology techniques such as cutting, 
rejoining, and degrading through several enzymes (63). For example, numerous restriction 
enzymes can be used to cut the nucleic acid nanostructures in a specific sequence-dependent 
manner. The enzymes cut the fragment of nucleic acids into two or more fragments at specific 
designated sequences on the nucleic acid nanostructures. For instance, Liu and coworkers 
employed BamHI and EcoRI restriction enzymes to controlled the deformation of DNA 
hydrogels (64). Also, several sub-classes of ligase enzymes rejoin two fragments of nucleic acids 
by catalyzing the formation of the phosphodiester bond between 3’-hydroxyl and 5’-phosphate 
groups of two nucleotides under cofactors such as ATP and NAD (65-68). To demonstrate the 
use of the ligase enzymes, Luo and coworkers pioneered the construction of higher-ordered DNA 
nanostructures by ligating Y- and X-shaped DNA building blocks to form dendrimer-like DNA 
nanostructures and networked DNA hydrogels, respectively (69, 70). Degradation of the nucleic 
acid can also be achieved by the presence of multiple endo- and exo-nuclease enzymes. Each of 
the degrading nucleases is unique in digesting different nucleic acid nanostructures. For example, 
Deoxyribonuclease I (DNase I) cleaves single- and double-stranded DNA at phosphodiester 
bonds leaving free 3’ OH groups. Besides DNase enzymes, ribonuclease enzymes are only 
specific to RNA molecules. For instance, ribonuclease H (RNase H) only degrades the 
phosphodiester bond of the RNA hybridizing to DNA in a DNA/RNA hybrid rendering a 
possibility to control the presence of RNA in the DNA/RNA nanostructures (71). Furthermore, 
several functional groups can be added on the nucleic acid structures by molecular enzymes. For 
instance, kinase enzymes can add or remove phosphate groups from the 5’ end of the nucleic 
acid structures. Terminal transferase enzymes catalyze the addition of single deoxynucleotide to 
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the 3’ end of single- and double-stranded DNA. Further details in using molecular techniques in 
manipulating nucleic acid structures can be found in the review by Luo (63). 
 
1.3 Self-assembly of nucleic acid structures for biomedical applications 
It has been well-demonstrated that nucleic acid-based materials have been used in a variety of 
applications ranging from mechanical to biological aspects such as charge capacitors, electronic 
nanodevices, biosensors, bioimaging devices, drug and gene delivery carriers, and in vitro 
protein production (72-77). In this dissertation, only nucleic acid-based materials that are 
employed in biomedical applications are included and categorized based on the self-assembled 
nucleic acid structure. For broader use of nucleic acid structures, several exclusive DNA and 
RNA nanotechnology reviews can be found elsewhere (15, 18, 78-81) 
1.3.1 Self-assembled nucleic acid building blocks  
Nucleic acid building blocks are nano-sized subunits self-assembling into high-ordered nucleic 
acid structures in a controllable fashion. The building blocks, here, are classified into 3 
categories including linear, branched, and loop structures. First, a linear building block, which 
naturally occurs in biological organisms, is used as a short rigid fragment under the persistence 
lengths. Nonetheless, the short single-stranded nucleic acids, mostly DNA, lack complexity and 
capacity to assemble into 3D structures. Thus, they are typically found in facilitating the 
construction of large templates such long single-stranded DNA and RNA molecules into 
rationally designed 3D structures (20, 82-84). Second, a branched building block is composed of 
at least three short oligonucleotides complementarily hybridizing to form branched 
nanostructures such as X-, Y-, and T-shaped nanostructures (18, 70, 85-87). Last but not least, a 
12 
 
loop structure typically founded in RNA occurring through the formation of secondary structures 
of single-stranded RNA molecules. The complementary sequences between two single-stranded 
RNA establish a stem leaving non-complementary sequences forming a bulge at the end of the 
stem. The RNA loops can complementarily interact with the loops nearby and stably form 
interlocking loop structures such as dimers, trimers, and hexamers (86, 88-90). An important 
RNA loop building block playing a key role in nucleic acid nanostructures is an aptamer. The 
aptamers are obtained from a large pool of random single-stranded nucleic acid sequences 
undergoing in vitro selection process called “SELEX” (91, 92). The ultimate nucleic acids with 
highly conserved sequences create tight and specific binding affinity to a target ligand such as 
organic molecules, proteins, and living cells, to name but a few (91-97).  
1.3.2 Nucleic acid structures for biomedical applications 
Exerting nucleic acid nanostructures in biomedical applications have gained tremendously 
interests due to the following aspects. To begin with, nucleic acid building blocks are rationally 
designed and precisely controlled in sizes, stiffness, and properties rendering a reduce in side 
effects and material homogeneousity in both in vitro and in vivo (14). Lastly, nucleic acids are 
biodegradable and biocompatible materials that can be innately metabolized by natural 
mechanisms and the degraded byproducts are biological metabolites. So far, there are a variety of 
biomedical systems taking advantages of nucleic acid structures to improve the efficiency of 
their system.  
 First, the nucleic acid structures are used to improve the efficiency of biosensing and nucleic 
acid detection. The nucleic acid structures hold anisotropic properties, thus different functional 
moieties can be spatially manipulated on such as dyes, small molecules, proteins, and specific 
sequences (74, 86). For instance, multi-functional dendrimer-like DNA nanostructures so-called 
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“nanobarcodes” were simultaneously used to detect multiple pathogenic DNA and distinguish 
each target by exploiting the different color ratios from two fluorescence dyes (69, 74). In 
addition, DNA tile nanostructures rationally designed to have target probe sequences protruding 
out from the tiles were introduced to label-free detect RNA by an assistance of atomic force 
microscope (AFM) (98). The RNA targets were hybridized to probe sequences increasing the 
tiles’ stiffness which can be detected by AFM’s cantilevers. Besides nucleic acid detection, DNA 
tiles demonstrated an ability to detect protein molecules with high specificity and sensitivity (99). 
In the study, small DNA tiles with modified thrombin-binding aptamers were self-assembled into 
large DNA nanoarrays with a high local density of the aptamers. An increase in the aptamer’s 
local density facilitates low concentration detection of human thrombin proteins in the solution.  
Moreover, the short single-stranded DNA building blocks are used in bridging between small 
molecules and nanoparticles resulting in aggregation and changes in colors, structures, and 
plasmonic properties, to name a few (100, 101).  
 For in vitro protein production, a cell-free protein producing DNA hydrogels have been 
addressed to advance the yield of conventional solution-based protein synthesis (72). The genes 
were tethered inside the DNA hydrogels by rationally designing the complementary sticky ends 
between the genes and branched DNA building blocks. At least 16 proteins have been 
successfully reported with fully functional activities after purification. Another benefit of this 
protein producing gel format is that the genes were entrapped inside the DNA hydrogels 
protecting the removal of the gene templates during the products’ purification steps. 
 Additionally, nucleic acid nanostructures are widely used as vessels for drug and gene 
delivery. Numerous types of building blocks self-assemble into a variety of 3D complex nucleic 
acid nanostructures with empty pockets potentially carrying siRNA, drug, and small molecules 
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(86, 88, 102-106). In some cases, the drug-carrying nucleic acid nanostructure itself can 
simultaneously hold therapeutic functionalities. In one example, Tuberfield and co-workers 
demonstrated that 3D DNA tetrahedral cages could substantially transfect human embryonic 
kidney (HEK) cells without any transfection reagents (104). Recently, Anderson et al. modified 
the 3D DNA tetrahedral nanostructures with several cellular-enhancing molecules to carry 
siRNA up to 6 molecules and delivered the nanostructures into mice for in vivo studies (106). 
Another example was to use cells-targeting aptamers on doxorubicin- encapsulating icosahedra 
DNA nanostructures to overcome multi-drug resistances in various cancer cells (86, 107). 
Furthermore, two complementary single-stranded siRNA were used not only to silence targeted 
genes, but also trigger the formation of polymeric nanoconstructs (105). Similarly, siRNA- 
carrying RNA microsponges were purposed to carry high copies of siRNA which can be entirely 
cleaved by Dicer enzymes for potent gene silencing (108). Other RNA building blocks such as 
X- and Y-shaped nanostructures were also specifically and rationally designed to carry different 
siRNA molecules giving highly accurate siRNA ratios for multimeric gene silencing in one shot 
of treatments  (85, 109-111). In addition to drug and gene delivery, nucleic acid nanomaterials 
also shade some light on tissue engineering and regenerative medicine applications. The 
synthetic DNA hydrogels were previously purposed to simultaneously encapsulated cells under 
physiological conditions (70). Preliminary results from Chinese Hamster Ovary (CHO) cell- 
encapsulating DNA hydrogels showed no sign of cellular toxicity both in vitro and in vivo.  
 
1.4 Challenges and future perspective 
To date, the utilization of synthetic nucleic acids as nanomaterials has been rapidly gaining 
interests in biomedical applications. It is because the precisely controlled physical and chemical 
15 
 
properties of nucleic acids. Also, the synthetic nucleic acids can identically exert molecular 
biology techniques as the same as the natural nucleic acids. With these great advantages, a 
number of biomedical applications embrace nucleic acid nanotechnology to alleviate critical 
issues in the fields such as degradability and biocompatibility of materials. Along with fortunate 
natural-like properties, synthetic nucleic acid nanomaterials are unpleasantly sensitive to several 
factors under physiological conditions. The current straight forward solution is to modify nucleic 
acid structure components including phosphate groups, sugar rings, and nucleobases. Chemical 
and enzymatical syntheses are the current methods to generate modified nucleic acids. 
Unfortunately, the length, cost, degree of modification, and yield of the synthetic nucleic acid 
production are still bottlenecks in freely manipulating modified nucleic acids for biomedical 
applications. Momentarily, several emerging advanced technologies producing efficient modified 
nucleic acids are of interest to conquer those limitations (112, 113). Nevertheless, with synthetic 
nucleic acids, some biological properties have been diminished or inactive owing to the non-
natural changes in the chemical structures. Thus, one must take a compromise between 
advantages of modification and damages of biological activity of the nucleic acid nanomaterials. 
Another important challenge of utilizing nucleic acid materials in biomedical applications is 
when the materials are operated in vivo. In general, the half-lives of natural nucleic acids in fetal 
bovine serum (FBS) are in the ranges of several minutes. The modification and self-assembly of 
synthetic branched nucleic acids prolong the half-lives from minutes to hours. In addition to 
prolonging the half-lives, the nucleic acid materials also need to be delivered to targeted cells 
and to be non-fouling to circumvent non-targeted side effects and minimize the adsorption of 
proteins, respectively (114). Consequently, solitary modified nucleic acid nanomaterials might 
not fulfill these requirements for in vivo treatments. Hence, the impetus in incorporating 
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supplemental molecules to achieve all essential needs resulting in complicated systems that are 
needed to be carefully evaluated before performing in vivo. 
All in all, the nucleic acid nanomaterials have demonstrated attractive properties that are very 
beneficial to biomedical fields. While widely used in several applications, a number of pitfalls in 
exerting the nucleic acid nanomaterials are still challenges and waiting to be improved. As a 
consequence, there is a plenty of room to improve the use of nucleic acid nanomaterials for an 
efficient biomedical applications. 
 
1.5 Significance of this dissertation 
Since the concept of DNA nanotechnology has established by Seeman et al., a plethora of 
biomedical applications employing nucleic acid structures has been purposed. The synthetic 
nucleic acid structures render accurately controlled structures reducing the degree of material’s 
dispersity, hence, diminishing heterogeneous drug loading per the nucleic acid structure. Another 
advantage of using nucleic acid nanomaterials in biomedical application is that synthetic and 
natural nucleic acid components are identical allowing identically natural molecular biology 
techniques to manipulate complicated synthetic nucleic acid structures. The degraded byproducts, 
in addition, are naturally non-toxic under physiological conditions. Hence, the works discussed 
in this dissertation specifically focus on employing nucleic acid nanomaterials for the co-delivery 
of drug and delivery and for 3D cell culture system. Firstly, I used novel DNA-lipid amphiphiles 
self-assembling into liposome-like structures named DNAsomes. The DNAsomes employed 
multifunctional properties. To begin with, the DNAsomes naturally carries siRNA molecules and 
cancer drugs by hybridizing and intercalating, respectively, enabling an efficient co-delivery 
17 
 
system. Furthermore, the DNAsomes can spatially conjugate with fluorescent dyes and track the 
delivery routes inside cells. The co-delivering DNAsomes improve efficiency and enhance 
synergistic of the delivery which ultimately reduce the dose of drugs required. Secondly, I will 
purpose the use of synthetic DNA hydrogels as a novel hydrogel-based scaffold for 3D cell 
culture. The synthetic DNA hydrogels, as earlier discussed, can undergo the same biological 
reactions as natural DNA. As a result, the synthetic DNA hydrogels can be either naturally 
degraded in the presence of nuclease-containing cell culture media or harvested on-demand by 
the enzymatic reactions. Thus, the synthetic DNA hydrogel-based scaffold can see its application 
in 3D cell culture as it will allow cellular mechanisms to naturally process the materials over 
time once they are implanted in vivo. Lastly, I will present the novel siRNA-DNA chimera 
hydrogels for in situ siRNA encapsulation and controlled releases. The synthetic DNA hydrogels 
are used to tether small siRNA molecules. The releases of siRNA are only governed by RNase H 
enzymatic reaction. I will also demonstrate a potential in employing the siRNA-DNA chimera 
hydrogels for a two-in-one siRNA delivery and 3D cell culture platform platform which can be 
useful for siRNA delivery of 3D cell spheroids.  
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CHAPTER 2 
Synthetic branched DNA structures for a co-delivery of 
 therapeutic drugs and siRNA 
2.1 Introduction 
In drug delivery systems, a plethora of synthetic nanocarriers have been demonstrated to 
efficiently deliver therapeutic molecules into living cells due to their controllability in physical 
and chemical properties (115). The synthetic nanocarriers play several important roles in 
increasing drug delivery efficiency. To begin with, tunable synthetic materials were tailored to 
increase drug solubility and encapsulate drugs, thereby providing an efficient way to shuttle 
drugs across cellular membrane (116). Moreover, the delivery by nanocarriers, in addition to 
increasing drug uptake, demonstrated bypassing drug-efflux pumps which are known to be one 
of the mechanisms causing multidrug resistance (MDR) (117-120). Additionally, the size ranges 
of nanocarriers are able to escape from the  renal clearances resulting in an increase in drugs’ 
half-life in circulating systems (114). Thus far, a number of materials have been implicated as 
potential nanocarriers such as lipid-based vesicles (micelles and liposomes), vesicle-like 
polymers (polysomes), and inorganic nanoparticles (114, 116, 121, 122). One of the most 
traditional drug nanocarriers is lipid- based vesicles comprised of both natural and synthetic lipid 
molecules, which self-assemble by re-hydrating dried lipid films in aqueous solution into 
vesicles with hollow cores.  
 Several forms of therapeutic agents have been accepted as they demonstrated potent 
therapeutic effects such as DNA, siRNA, antibodies, and peptides (123, 124). Through medical 
advancement, emerging nanocarriers carrying multiple therapeutic agents on the same carriers 
have been proposed to elevate poor therapeutic efficiency of individual drugs especially in 
cancer treatments (119, 122). The co-delivery of therapeutic agent combinations has been 
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confirmed the combined and synergistic effects compared to individual multi-drug treatments 
(119, 125-127). For instance, the co-delivery of Bcl-2 siRNA or antisense molecules and 
Doxurubin (Dox) exhibited enhanced chemotherapic efficiency in lung cancer models (119, 128). 
The Bcl-2 siRNA molecules are responsible for Bcl-2 anti-apoptosis protein inhibition and, thus, 
enhancing apoptotic pathways in cancer cells (129). Along with the Bcl-2 gene inhibition, Dox 
inhibits DNA replication by intercalating nucleobases which prevent a DNA unwinding process 
and induce cell death. These combined actions accelerated the toxicity level to investigated lung 
cancer cells.  
 Physical entrapment and chemical conjugation are the two main mechanisms that are 
responsible for therapeutic agent loading. First, the therapeutic agents are embedded inside self-
assembling vesicles and nanoparticles inside the hollow-core structures. Second, several 
chemical conjugations are found to immobilize the therapeutic agents onto nanocarriers’ surface.  
 Even though several co-delivery platforms have been reported in the past decades, issues 
regarding the synthesis of materials, such as difficulty in obtaining high therapeutic agent 
loading pose persistent challenges (115, 121). For example, in lipidic-based platforms, the 
resulting lipid-based carriers are inconsistent in size and therefore drug-loading efficiency. In 
polymer-based platforms, most of polymersomes are synthesized under harsh conditions which 
are deadly toxic to living cells. The polymer materials are also non-degradable by natural 
metabolisms. Inorganic-based materials, similar to polymersomes, cannot be metabolized and 
possibly accumulate after the delivery which can cause cellular toxicity. Additionally, 
formulating various therapeutic agents into one nanocarrier is more challenging especially when 
different types of therapeutic agents are encapsulated and precise multiple drug ratios of are 
required for the co-delivering systems (127).    
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In contrast to the aforementioned mentioned synthetic nanocarriers, synthetic self-assembled 
DNA nanomaterials are biodegradable, spatially controlled, and monodisperse materials. The 
biodegradable synthetic DNA materials are naturally degraded in the presence of nucleases 
which conveniently metabolize the DNA into nucleotides. Also, the precise controls are due to 
their well-defined sequences, which self-assemble by complementarily specific base-paring,such 
as X-, Y-, T- DNA building blocks and higher ordered structures including tetrahedron and cubic 
structures. Previously, branched synthetic DNA nanomaterials have demonstrated several 
properties and characteristics such as multivalency, monodispersity, anisotropicity, spatial 
controllability and a number of functional group modifications (130). Here, we further 
investigate DNA’s base-pairing and its intercalating properties for an inherent siRNA and small 
drug carrier. By combining vesicle-like self-assembling properties of lipids, we are able to create 
a novel lipid-DNA core-shell-like structure called DNAsome in which its size, siRNA, and drug 
loading capacity can be precisely and spatially controlled.  
 
2.2 Design and Synthesis of multivalent and anisotropic branched DNA-lipid amphiphile 
building blocks 
The building blocks for self-assembling DNAsomes consist of Y-shaped DNA conjugated to 
lipid molecules. The Y-shaped DNA structures were comprised of three single-stranded 
oligonucleotides designed to have half of the sequences of one strand complementarily hybridize 
to that of adjacent strands. The 5’ end of each oligonucleotide was designed to orthogonally react 
with various functional groups. For this specific multifunctional delivery application, each of the 
5’ end of the three oligonucleotides was rationally modified with primary amine groups (-NH2) 
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for lipid conjugation, tracer fluorescent dyes for in situ cellular tracking, and 21 nucleotide 
complementary sequences of an antisense siRNA molecules as shown in figure 2.1. The equal 
moles of three functionalized oligonucleotides self-annealed to Y-shaped DNA building blocks 
by increasing and slowly decreasing the temperature from 95 °C to 4 °C. The multivalent Y-
shaped DNA building blocks were then covalently conjugated to N-glutaryl 
phosphatidylethanolamine (NGPE) lipid molecules by reacting between active ester groups on 
NGPE and primary amine on the 5’ end of the Y-shaped DNA building blocks (Figure 2.2a). The 
conjugation between the Y-shaped DNA building blocks and NGPE molecules generated a new 
covalent amide bond rendering amphiphilic properties to the DNA-lipid amphiphile building 
blocks. In addition to amphiphilic properties, the DNA-lipid amphiphile building blocks 
inherently contain nucleic acid properties where functional nucleic acids including siRNAs, 
aptamers, and antisense oligonucleotides can naturally hybridize to the structures without further 
modification. In order to confirm the formation of the new amide bonds, high performance liquid 
chromatography (HPLC) was used to characterize the amide bond formation. The results from 
HPLC indicated an extra peak, thereby confirming the new amide bond formation in the DNA-
lipid amphiphile building blocks (Figure 2.2b). Non-reacted lipid molecules, Y-shaped DNAs, 
and DNA-lipid amphiphile building blocks were labeled as A, B, and C, respectively and 
purified from the DNA-lipid amphiphile building blocks. Moreover, we characterized the HPLC 
products by 3% agrose gel electrophoresis to confirm the formation of the lipid-DNA building 
blocks as the smear band presented in lane 2 (Figure 2.2c). Additionally, fourier transform 
infrared (FT-IR) spectroscopy revealed transmission bands from the amide bonds (N-H bending 
vibration) at around 1660 cm-1 and 1590 cm-1 (black line) compared with negative bands on 
branched NH2- modified DNA (red line) and DNA structure controls (blue line) (Figure 2.2d).   
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Figure 2.1. Schematic illustration of the construction of DNAsome for the delivery of RNAi 
agents. DNAsomes and functional groups are not drawn to scale. The resultant DNAsome 
possesses not only the capability and capacity to store drugs and siRNA, but also molecular 
probe ability. 
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Figure 2.2. Preparation and characterization of Y-DNA-lipid amphiphiles. a. Synthesis of Y-
DNA-lipid amphiphiles. The Y-DNA-lipid conjugates were achieved through reactions between 
the amine modified groups of Y-DNA and the activated ester groups of the lipid molecules. 
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Figure 2.2. Preparation and characterization of Y-DNA-lipid amphiphiles (continued). The final 
products were obtained by performing HPLC purification to ensure removal of unreacted 
reagents as well as impurities. b. HPLC chromatogram of products formed in the reaction of Y-
DNA and lipid. The separation of unreacted lipid (A), NH2-Y-DNA (B), and Y-DNA-lipid 
conjugate (C) were achieved by a gradient elution. The elution time (min) is on the x-axis; the 
ultraviolet absorbance at 260 nm (mV) is on the y-axis. c. Mobility shift of Y-DNA and lipid 
conjugates. Gel electrophoresis of HPLC fractions was conducted at a constant voltage of 90 
volts for 60 min. (3 % agarose gel) Lanes 1 2 and 3 indicate NH2-Y-DNA, Y-DNA-lipid 
conjugate and Y-DNA + lipid mixture, respectively. d. FT-IR spectroscopy. FT-IR spectrum of 
Y-DNA-lipid conjugates revealed transmission bands from an amide bond. The IR spectrums of 
lipid conjugated Y-DNA confirm the presence of amide I band (C=O stretching vibration) and 
amide II band (N-H bending vibration) at around 1660 cm-1 and 1590 cm-1 (black line). These 
results show carboxylated lipid and amine modified Y-DNA formed amide bonding through 
reaction between a carboxylic group and amine group. However, amine modified Y-DNA shows 
only N-H bending vibration at around 1630 cm-1 (red line) and Y-DNA do not show any band 
(blue line).  
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2.3 Formation and Characterization of DNAsomes 
To self-assemble DNAsomes, purified DNA-lipid amphiphile building blocks were dialyzed 
against water in a cellulose membrane bag to form liposome-like DNAsomes. Consequently, the 
liposome-like DNAsomes were freeze-dried and collected as dried products for later drug and 
siRNA loading. After dialysis, several techniques were utilized to characterize the  morphology 
and properties of DNAsome. We first began to investigate the minimal concentration of DNA-
lipid amphiphile building blocks required to assemble liposome- like DNAsome structures by 
determining critical micelle concentration (CMC) (Figure 2.3a). We used pyrene, a tetracyclic 
hydrophobic molecule, as its the fluorescence intensity is highly sensitive to the solvent polarity. 
The pyrene fluorescence probes are poorly solubilized in aqueous phase but strongly partition in 
hydrophobic environment, in this case DNAsome structures. The DNA-lipid amphiphile building 
block was varied from 0.01 to 2190 nM. At 17 nM concentration, the fluorescence intensity ratio 
dramatically increased, thereby demonstrating the formation of DNAsomes. 
Moreover, we used förster resonance energy transfer (FRET) to obtain the internal packing 
information between each DNA- lipid amphiphile building block inside the DNAsomes (Figure 
2.3b). The two fluorescence FRET pairs, Cy5 (red) and green Cy3 (green), were individually 
labeled to the DNA-lipid amphiphile building blocks. The fluorescence intensity (I) between Cy5 
(IR) and Cy3 (IG) was used as the intensity ratio (IR/IG) to determine the distance between the 
DNA-lipid amphiphile building blocks organized inside the DNAsomes. In the FRET 
experiments, a simple mixture of Cy3-, Cy5- DNA building blocks, and unlabeled free lipid 
molecules were used as a control. Two species of Cy3- and Cy5- labeled DNAsomes were mixed 
and assembled as a sample. The IR/IG was 3.2 times higher for the DNAsome than for the control. 
This result suggests that the internal structure of DNAsomes consisted of the DNA-lipid 
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amphiphile building blocks that are closely-packed within FRET distance (< 10 nm). We further 
explored the structure packing and the core components by employing an electron energy loss 
spectroscopy (EELS) (Figure 2.3c). A phosphorous compound signal was detected, thereby 
confirming the presence of DNA phosphate groups at the dense core of the DNAsome structure. 
Dynamic light scattering (DLS) was employed to investigate the effects of the DNA-lipid 
amphiphile concentrations on sizes and charges (Figure 2.3d). The sizes of DNAsomes increased 
linearly from 110.7 ± 12.9 to 1102.5 ± 91.2 nm as the DNA- lipid amphiphile building block 
concentration increased from 0.5-11 µM. Within the same range of the concentration, the zeta 
potentials also showed a linear relationship from -10.77 ± 0.81 mV to -35.60 ± 1.27 mV. It is 
notable that as the concentration of DNA amphiphile increases, both the surface area per particle 
and the volume per particle increase more rapidly than the zeta potential. Thus, the charge per 
unit area (and per unit volume) decreases with increasing DNA- lipid amphiphile building block 
concentration, and consequently the DNAsomes become less repulsive to the building blocks. 
These results suggest that, unlike conventional liposomes, the size of our DNAsomes can be 
precisely controlled over a wide range simply by adjusting the concentration of Y-DNA 
amphiphiles. Last but not least, we investigated the morphology of the DNAsomes. The 
morphology was observed by a confocal microscopy technique (Figure 2.4a).  The fluorescent 
dyes were covalently attached to the 5’ end of the DNA-lipid amphiphile building blocks as 
previously described. The DNAsomes were observed as spherical core-shell structures with a 
dense core and hollow region in the center surrounded by a low-density shell. Similarly, the 
core-shell structures with dense core morphologies were also observed with scanning 
transmission electron microscope (STEM) (Figure 2.4b).  
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Figure 2.3. Characterization of DNAsomes. a. Critical Micelle Concentration (CMC) The 
concentration of Y-DNA amphiphile was varied from 0.01 nM to 2190 nM. Here, pyrene was 
used as a fluorescent probe (no other fluorescent dyes were used in these experiments to prevent 
interference). b. Fluorescence intensity of free lipids and Y-DNA mixture (green), and 
DNAsomes made by Y-DNA amphiphile (orange) was compared by Fluorescence resonance 
energy transfer (FRET). c. Phosphorus EELS spectra of DNAsomes. Phosphorus signal is 
detected in the core of DNAsomes. Raw EELS spectra from DNAsomes (inset) are shown where 
the black spectrum is taken from the core. The spectra are scaled so that the pre-edge intensity is 
the same. The scale bar is 500 nm. d. Zeta potential and size distribution of DNAsomes as a 
function of Y-DNA amphiphile concentrations.  
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Figure 2.4. Morphology characteristic of DNAsomes. a. Confocal microscopy image of self-
assembled DNAsome. The scale bar is 5 µm. b. ADF-STEM image of DNAsomes. The ADF-
STEM image shows the spherical shape of the DNAsomes that contain a dense core. The scale 
bar is 500 nm. 
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2.4 DNAsomes as a co-delivery nanocarrier 
Due to the unique characteristics of DNAsomes, both DNA and RNA can be inherently attached 
by complementary base-paring to spatially designed sequences on the DNAsomes’ structure 
rendering DNAsomes as an inherent gene carrier. Prior to performing in vitro siRNA transfection, 
we first evaluated the cellular toxicity of DNAsomes and compared with that of commercial 
transfection reagents including Lipofectamin2000 (L2K) and DOTAP by MTT (3-(4, 5-
dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide). Chinese Hamster Ovarian (CHO) cells 
were used as model studies through the experiments. Nearly 100% cell viability of CHO cells 
was obtained after incubating with DNAsomes for 24 hours while L2K and DOTAP reduced cell 
viability to about 80% and 40%, respectively (Figure 2.5). Next, we compared the siRNA 
transfection efficiency of DNAsomes to that of L2K and DOTAP at each reagent’s optimum 
conditions. A house-keeping GAPDH gene was used as a model mRNA target. GAPDH siRNA-
loaded DNAsomes were prepared by re-dissolving dehydrated DNAsome products with equal 
molar of single-stranded GAPDH siRNA in PBS buffer overnight. L2K and DOTAP were 
prepared by suggested manufacturing protocols. At optimal conditions, DNAsomes 
demonstrated about 46% siRNA transfection efficiency (Figure 2.6a) which is comparable to 
L2K (Figure 2.6b) and DOTAP (Figure 2.6c) but remained significantly higher cell viability than 
the other two reagents. This result might be attributable to the fact that DNAsomes are entirely 
made of negatively charged DNA and neutral lipid exhibiting overall negatively charged while 
typical transfection reagents are made of cationic polymers exhibiting positively-charged which 
are well-known to be highly toxic to the cells. 
 
2.5 Intracellular uptake and mechanism studies of DNAsomes 
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Figure 2.5. Cell viability of transfection reagents. Viability of CHO cells after incubation with 
the various transfection reagents (Lipofectamin2000 (L2K), DOTAP, and DNAsome) as 
measured by by the MTT assay.  
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Figure 2.6. Transfection efficiency of siRNA-based transfection reagents. a. % Remaining 
GAPDH expression after the cells were transfected with DNAsomes from CHO cells. b. % 
Remaining GAPDH expression, finding with L2K and c. % Remaining GAPDH expression, 
finding with DOTAP. 
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To determine a cellular uptake pathway of DNAsomes, fluorescence-labeled DNAsomes were 
incubated with CHO cells at 4 and 37 °C to primarily determine if the uptake mechanism 
depends on endocytotic mechanisms. Z-directional sliced images observed by a confocal 
microscope presented fluorescence signals inside the cells only at 37 °C, thereby confirming the 
characteristic of endocytosis (Figure 2.7). Sub-endosomal uptake mechanisms were also studied 
by pre-treating various endocytotic inhibitors before transfecting the cells with GAPDH siRNA-
loaded DNAsomes (Figure 2.8). Three major endocytotic pathways comprising caveolae-
mediated, actin-mediated, and microtubules- dependent pathways were suppressed by filipin 
complex, cytochalasin B, and nocodazole, respectively. The condition that cells were transfected 
with GAPDH siRNA-loaded DNAsomes was used as a non-inhibiting control. The caveolae- 
mediated endocytosis was predominantly responsible for a main uptake pathway for DNAsomes 
because, in fact, the filipin complex totally avert the GAPDH protein activity inhibition. Also, 
DNAsomes can alternately enter the cells via the actin-mediated pathway and microtubules-
facilitated pathway as partial GAPDH protein activity inhibition was found when cytochalasin B 
and nocodazole were presented in the transfection. Notably, the z-directional sliced confocal 
images also showed the fluorescence-labeled siRNA localized in both cytoplasm and nuclease of 
the cells, thereby demonstrating a potential in deliverying siRNA or drugs throughout the entire 
cells.  
 
2.6 Drug loading and Characterization of drug-loaded DNAsomes 
To further study the potential of co-delivering small drugs and siRNA molecules, a cancer 
intercalating drug, doxorubicin (Dox), was used in the model study. Dox is a widely-used 
hydrophobic drug in several cancer treatments. Its planar structure plays an important role in 
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inhibiting growth of cancer cells by impeding the DNA replication (Figure 2.9c). Thus, in 
addition to being embedded in hydrophobic lipid layers of the DNAsomes, Dox can be loaded in 
DNAsomes by interacting in the groves of the DNA doubled helix. The loading mechanism was 
simply obtained by mixing the dehydrated DNAsome with Dox at room temperature by slow 
shaking overnight. The resulting Dox-loaded DNAsomes were then centrifuged to remove non-
encapsulated Dox (Figure 2.9d). Also, we compared the change in sizes after Dox loading by 
DLS techniques and found that narrow size distributions were obtained with an average size of 
254 nm and 322 nm for before and after Dox loaded DNAsomes, respectively (Figure 2.9a, b). 
After Dox and siRNA loading, we first characterized the controlled release profiles of Dox and 
siRNA in PBS buffer (Figure 2.9e). Both Dox and siRNA continuously released from 
DNAsomes with distinct releasing properties. This could due to the fact that Dox and siRNA 
have different binding affinities to DNAsomes which are intercalation and hybridization, 
respectively. 
 
2.7 A co-delivery of DNAsomes for synergistic effects 
Co-delivery of several drug combinations has been demonstrated to increase the efficiency in 
treating a number of cancers (116, 119, 127).  To demonstrate the use of DNAsomes as a co-
delivering nanocarrier, we chose Dox and Bcl-2 siRNA that have been reported to exhibit 
combined effects as our model drug combination study (119). In vitro co-delivery studies of 
DNAsomes were determined by quantifying cell viability after treating with Dox-siRNA- loaded 
DNAsomes. The concentration that causes 50% cell toxicity (IC50) was used to determine the 
efficiency of co-delivering measured by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) (MTT) assay (Figure 2.10). In control experiments, we individually treated CHO cells 
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Figure 2.7. Confocal microscopy images of DNAsomes delivered to CHO cells. a-d. DNAsomes 
were hybridized with fluorescence-labeled siRNA (red) and transfected into CHO cells (blue, 
nuclei; green, actin) at 37 ºC overnight. Confocal images were used to project side views (Z-
directional slices) of CHO cells, thereby exhibiting the intracellular delivery of siRNA-labeled 
DNAsomes. The scale bar is 10 μm. 
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Figure 2.8. Investigation of the endocytosis mechanism for DNAsomes. The cellular endocytosis 
mechanism of our DNAsome was investigated by endocytosis inhibition studies. Cells were 
incubated with filipin complex to inhibit caveolae-mediated endocytosis.Cytochalasin B and 
nocodazole were also used to disrupt actin-mediated and microtubules-dependent endocytosis 
pathways, respectively. The control contained no inhibitors 
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with free Dox, free Dox with siRNA, and Dox-loaded DNAsomes. As expected, the IC50 of free 
Dox and free Dox with siRNA at 59 µM was dramatically reduced to 5 µM when Dox-loaded 
DNAsomes were used in the study. Once both Dox and siRNA were encapsulated in DNAsomes, 
the IC50 was much reduced from 5 µM to about 2 µM when Dox and siRNA- loaded DNAsomes 
were employed, thereby supporting the synergistic co-delivering approach by the DNAsome 
nanocarrier.  
 
2.8 Conclusion  
In sum, we have proposed a novel multivalent and anisotropic liposome-like core-shell 
structure nanocarrier called DNAsomes. The DNAsomes are obtained from the self-assembly of 
DNA-lipid amphiphile building blocks. Each 5’ end of Y- shaped DNA structures are spatially 
conjugated to three functionalities including siRNA, lipid molecules and fluorescent dyes. The 
sizes and surface charges of the DNAsomes can be finely tuned by altering building block 
concentrations. Additionally, the DNAsomes can carry a siRNA through inherently 
complementary base-pairing properties. Similar to siRNA, other therapeutic nucleic acids such 
as an antisense oligonucleotide, functional gene, and aptamer, can be naturally loaded in the 
DNAsomes by employing the same concept of inherent hybridization. To the best of our 
knowledge, this is the first report to utilize the multivalent and anisotropic DNA- lipid 
amphiphile building blocks for co-delivering drugs. We expect to achieve multiple drug delivery 
by altering the branched DNA structures in the building blocks for future drug delivery 
applications.  
 
2.9 Materials and methods  
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2.9.1 Synthesis of Y-DNA building blocks  
All chemicals utilized in this study were obtained from Sigma-Aldrich (St. Louis, Missouri) 
unless otherwise mentioned. The Y-DNA building blocks were designed and synthesized 
according to the previous papers published by our group. All oligonucleotides including 
fluorescent labeled oligonucleotide strands were commercially synthesized with standard 
desalting (Integrated DNA Technologies, Coralville, Iowa). Table 2.1 and 2.2 show 
oligonucleotide sequences utilized in this experiment. Briefly, oligonucleotides were dissolved in 
annealing buffer (10 mM Tris, pH = 8.0, 1 mM EDTA and 50 mM NaCl) with a final 
concentration of 0.2 mM. Y-DNA was synthesized by mixing the same molar amount of 
corresponding oligonucleotide strands. The nomenclature is as follows: Y01, Y02, and Y03 are the 
three corresponding single oligonucleotide chains that form a Y-DNA. Hybridizations were 
performed according to the following procedures: (1) Denaturation at 95 °C for 2 min. (2) 
Cooling at 65 °C and incubation for 2 min. (3) Annealing at 60 °C for 5 min. (4) Further 
annealing at 60 °C for 0.5 min with a continuous temperature decrease at a rate of 1 °C per min. 
The annealing steps were repeated a total of 40 times. The final annealed products were stored at 
4 °C. 
  
2.9.2 Construction of the DNA-lipid amphiphiles and DNAsome  
Succinyl NGPE (0.3 mg), 0.5 ml of 0.016 M octylglucoside in MES buffer (pH 5.5), EDC (2 
mM) and NHS (5 mM) were then reacted with shaking for 10 min and centrifuged at 2.5 kG for 
60 sec, followed by 20 µl of 0.1 M NaOH (pH 8.0) with repeated shaking and centrifugation. 
Mixtures were then added to the prepared Y-DNA products, and incubated for 4 hours at room 
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Figure 2.9. Drug loading and drug release profile of DNAsomes a. The average size of 
DNAsome before drug loading is 254nm. b. The average size of DNAsome after drug loading is 
322nm. c. The chemical structure of Dox d. Photograph of tubes containing Dox solution and 
Dox-loaded DNAsomes. e. Drug release profiles from Bcl2-siRNA (■), Dox- loaded DNAsomes 
(▲).  
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Figure 2.10. Co-delivery of Bcl-2 siRNA and Dox. Viability of CHO cells measured by MTT 
assay after incubation with free Dox, free Dox and free siRNA, Dox-loaded DNAsome, and 
Dox-loaded DNAsome hybridized with Bcl-2 siRNA, respectively. 
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temperature. High performance liquid chromatography (HPLC) was performed to remove non-
reacted products and the impurities. The running conditions were as follows: XBridge C18 
column equipped with a photo-diode array detector (Waters Corp, Milford, Massachusetts). The 
gradient used was 0–50% acetonitrile in 0.1 M triethylammonium acetate (TEAA, pH 7.0) as the 
mobile phase within 30 min at a flow rate of 1.0 mL/min with UV detection (260 nm). The 
functionalized Y-DNA-lipid amphiphiles was further dialyzed to prepare DNAsomes against 100 
ml of aqueous solution for 48 hrs using a cellulose membrane bag. After dialysis, DNAsomes 
were collected and frozen using a freeze-dryer system (Labconco Corp, Kansas City, Missouri) 
to achieve final products. 
2.9.3 Characterization of DNAsomes 
Fourier transform infrared spectroscopy (FT-IR)  
To characterize the conjugation of lipid and Y-DNA, FT-IR microspectra were used with 
Galaxy series FT-IR 5000 (GL5020, Mattson, Arizona). The spectra were scanned in the 
transmission mode from 4000 to 500 cm-1 with 100 scans per point and resolution of 4 cm-1. 
Each sample of 100 µl was squeezed between two BaF2 windows. 
Morphological study  
For the STEM imaging experiment, samples were prepared as follows: approximately 1 µl of 
DNAsomes was mixed with 100 µl of Tris (30 mM, pH 8.0) before 2.5 µl of 5 % 2, 4, 6 
Tri(dimethylaminomethyl phenol) (DMP) 30 was added to the mixture. A drop of the mixture 
(50 µl) was placed onto a sheet of parafilm and covered with a petri dish for 7 minutes at room 
temperature. The DNA molecules were then picked up by touching the drop with a carbon-
coated TEM grid (Electron Microscopy Sciences, Fort Washington, Pennsylvania), and were left 
covered with a petridish for another 3 minutes. The sample was then stained with 2 % uranyl 
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acetate (negative staining reagent) for 1 minute. The grid was then blotted with a filter paper and 
allowed to dry in air. The grids were visualized at a voltage of 100 kV using a FEI Philips 
TECNAI 12, after rotary coated with Pt/Pd.  
Critical micelle concentration measurement (CMC)  
The CMC of Y-DNA-lipid amphiphile in buffer/solvent was analyzed by fluorescence 
spectroscopy using pyrene as a hydrophobic fluorescence probe. Aliquots of pyrene solutions in 
acetone (20 μL of 30 μM pyrene) were added to empty tubes, and the acetone was allowed to 
evaporate overnight. Then, 90 μL of aqueous Y-DNA-lipid amphiphile solution with 
concentrations ranging from 0.01 nM to 2190 nM was added to the tubes. The solutions were 
equilibrated for 24 hours at room temperature. When Y-DNA-lipid amphiphile concentrations 
reach above the CMC, pyrene preferentially partitioned into the hydrophobic part of the 
assembled core/shell structures. As pyrene moved from hydrophilic to hydrophobic environment, 
its excitation and emission spectra both exhibited a shift. The fluorescent spectra of the samples 
were recorded with an SLM 8000c Spectrofluorimeter (SLM) at room temperature (20oC). The 
excitation spectra were recorded from 280 to 360 nm with an emission wavelength of 395 nm. 
The CMC of Y-DNA-lipid amphiphile was determined by plotting the intensity (peak height) 
ratio of the 339 nm peak to the 334 nm peak from the emission spectra versus the logarithm of 
polymer concentration. The CMC value was taken from the intersection of the tangent to the 
curve at the inflection with the horizontal tangent through points at low concentrations. 
Förster resonance energy transfer (FRET)  
To confirm the formation of DNAsome, Cy3 (donor) and Cy5 (acceptor) were chosen for 
fluorescence resonance energy transfer (FRET) experiments because of the large spectral overlap 
between emission spectrum of Cy3 and excitation spectrum of Cy5. Two Cy3 or Cy5 were 
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labeled on a single Y-DNA. With 540 nm laser light, FRET tests were performed by checking 
fluorescence intensity changes before conjugation of lipid and fluorescence dye labeled Y-DNA 
and after conjugation of lipid on Y-DNA upon emission at 565 nm and 665 nm. 
2.9.4 Cell culture, fluorescence, and transfection studies 
Cell maintenance  
CHO cells were cultured at 37 °C with 5% CO2 in Ham’s F-12K Nutrient Mixture, Kaighn’s 
Mod, F-12K (Mediatech, Manassas, Virginia) supplemented with L-Glutamine, 10% fetal bovine 
serum (FBS, Mediatech, Manassas, Virginia), and 1% penicillin/streptomycin (P/S, Mediatech, 
Manassas, Virginia). 
Fluorescence labeling and imaging of cell  
CHO Cells (2 x 104 cells) were cultured in a 25 cm3  flask and plated on the day of 
experiments by reverse transfection method. CHO cells in suspension media were then 
transfected and added to the well just before adding the 30 nM fluorescently labeled GAPDH 
siRNA-hybridized DNAsome in the presence of serum-free media (OPTi-MEM I, Invitrogen, 
Carlsbad, California) in each well on Lab-Tek chamber slides (8 wells, Permanox slide, Nunc) 
for 24 hours at 37°C. Then cells were washed three times with PBS and fixed with 4% 
paraformaldehyde. The method of staining cells by two fluorescent dyes were mentioned 
previously our papers (73). Briefly, actin filaments and nuclei were stained with Alexa Fluor488 
phalloidin (Invitrogen, Carlsbad, California) and DAPI (40,6-diamidino-2-phenylindole) with an 
antifade reagent (Invitrogen, Carlsbad, California) according to the supplier’s protocol. 
Fluorescence images of the cells were achieved by Zeiss LSM 510 Meta confocal microscope.                                                                                                                                                          
Transfection studies  
The antisense siRNA strand of Glyceralhehyde-3-Phosphate Dehydrogenase (GAPDH) and 
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non-complementary sequence of siRNA were obtained (Ambion, Inc., Austin, Texas) and 
synthesized as a single-stranded siRNA from IDT (Coralville, Iowa). The sequences are (5' - 
rArArA rGrUrU rGrUrC rArUrG rGrArU rGrArC rCrUrU - 3') for GAPDH siRNA and (5'- 
rCrCrG rUrArU rCrGrU rArArG rCrArG rUrArC rUrUrU -3') for non-complementary siRNA 
respectively. The single-stranded siRNA was hybridized to the DNAsome at the sticky end of the 
Y-DNA as described above. After hybridization, the siRNA-DNAsome complex was diluted in 
serum-free media (OPTi-MEM I, Invitrogen, Carlsbad, California) to 5 µL final volumes for 
each amount of siRNA. The amounts of GAPDH siRNA were varied at 10, 30, 90, and 180 nM. 
The molar ratio of DNAsomes and single-stranded siRNAs was 1:1. After CHO cells (1 x 104 
cells in 95 µL P/S –free media) were plated in each well of a 96-well plate, 5µL of prepared 
samples at different siRNA amounts were added and then mixed gently. The cells were 
incubated in the controlled-temperature at 37 °C with 5% CO2 incubator for 4 hours before all 
complex media were replaced by 200 µL of fresh serum-contained F-12K media. The plate was 
further incubated until 48 hours and was measured remaining GAPDH protein level by using 
KDalertTM GAPDH Assay Kit (Ambion, Inc., Austin, Texas) as per the kit’s protocol. Briefly, 
the supernatant was removed and washed three times with 1 x PBS buffer. 200 µL KDalert lysis 
buffer was added to each sample well. The plate was then kept at 4 °C for 20 minutes. After the 
cells were lysed, 10 µL of each sample was transferred to a clean 96-well plate. Next, 90 µL of 
KDalert Mix was quickly added and the fluorescence emitted was immediately measured every 
one minute by the real-time kinetic mode from a Synergy 4 Hybrid multi-mode microplate reader 
(Biotek Instrument, Inc., Winooski, Vermont) using a 560 nm excitation and a 590 nm emission 
filter. The kinetic reaction was run for 4 minutes.  
Investigation of endocytosis mechanism of DNAsomes uptake  
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To investigate the cellular endocytosis mechanism of DNAsomes, CHO cells (1x 104 cells) 
were trypsinized and plated in each well of a 96-well plate. Then, cells were pre-incubated with 
three endocytosis inhibitors for one hour at 37 ºC with 5 µg/mL of filipin complex, 5 µg/mL of 
cytochalasin B, and 10 µg/mL of Nocodazole, and 10% of DMSO only as a positive control. 
Cells were cultured with GAPDH and negative siRNA (30 nM) conjugated DNAsomes 
respectively for 4 hours. The new media was replaced and additionally incubated for 44 hours 
(total of 48 hours). An inhibition of endocytosis was determined by Ambion KDalert GAPDH 
assay (Austin, TX).                                                                                   
Cell cytotoxicity evaluation (MTT)  
The cytotoxicity of the DNAsome and siRNA-hybridized DNAsome was determined by 
MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) cell viability assay (ATCC, 
Manassas, Virginia). CHO cells were plated in 96-well plate at 8,000 cells per well. Next, the 
DNAsome and siRNA-loaded DNAsome at different concentrations was added and incubated for 
24 hours. Then, the supernatant was replaced by 120 µL of fresh full media and incubated for an 
additional 24 hours. After 48 hours incubation, 12 µL MTT reagent was added and cells were 
incubated for 2 hours and purple precipitate was observed. 100 µL of detergent reagent was then 
added and incubated in the dark at room temperature for another 2 hours. Absorbance was 
measured with a specific monochrome filter at 570 nm by the Synergy 4 Hybrid multi-mode 
microplate reader (Biotek Instrument, Inc., Winooski, Vermont). The cytotoxicity (%) of each 
sample was compared to control cells in full media.  
Drug loading and In vitro drug release measurements  
Two drug candidates (Bcl-2 siRNA and DOX) were selected to evaluate in vitro drug release 
profiles. To load model drugs, Cy5 labeled siRNA solution (60 µM, IDT, Coralville, Iowa) and a 
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doxorubicin (DOX) solution (20 ng/µL), which intercalates DNA, was prepared and incubated 
with DNAsome in 300 µL of distilled water for 48 hrs at room temperature under gentle shaking 
to allow both drugs to be encapsulated into DNAsome. After the loading process, each reaction 
solution was centrifuged at 14000 rpm for 20 min and the supernatant was removed to separate 
the unloaded drug from DNAsome. The DNAsome was then re-dispersed into 300 µL of PBS 
solution (pH 7.4) with gentle and continuous shaking (100 rpm) at 37 °C. The amount of DOX or 
siRNA released from the DNAsome was measured by fluorescence intensity (Doxorubicin 
excitation 480 nm, emission 550 nm and Cy5-siRNA excitation 650 nm, emission 670 nm). 
Cumulative drug release profiles were calculated based on the equation below  
Cumulative Drug Release [%] = (Mt / Mo) × 100 
where Mt is the amount of accumulated drug released from the DNAsome at time t, and M0 is 
the amount of drug loaded into the DNAsome. Here, M0 was calculated by subtracting the 
amount of unloaded drug from initial drug fed. 
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Table 2.1. Oligonucleotide sequences of the Y-DNA building blocks with fluorescent dyes for DNAsome 
synthesis  
Strand Sequence 
Y - DNA  
(FRET) 
Y01 5' - /NH2/ CTT ACG GCG AAT GTC ATG CGG ATC CA - 3' 
Y02 5' - Cys 3  - GGT CAT CCA TGA CAA CTT TAG GCT GAT TCG GTC ATT CGC CGT AAG - 3' 
Y03 5' - Cys 3  - TGG ATC CGC ATG AAC CGA ATC AGC CT – 3' 
Y - DNA  
(FRET) 
Y01 5' - /NH2/ CTT ACG GCG AAT GTC ATG CGG ATC CA - 3' 
Y02  5' - Cys 5  - AG GCT GAT TCG GTC ATT CGC CGT AAG -3' 
Y03 5' - Cys 5  -TGG ATC CGC ATG AAC CGA ATC AGC CT - 3' 
Y - DNA  
(Confocal)   
Y01 5' - /NH2/ CTT ACG GCG AAT GTC ATG CGG ATC CA - 3' 
Y02  5' - AG GCT GAT TCG GTC ATT CGC CGT AAG -3' 
Y03 5' – BODIPY 630/650  - TGG ATC CGC ATG AAC CGA ATC AGC CT - 3' 
Y - DNA  
(Control)       
Y01 5' - /NH2/ CTT ACG GCG AAT GTC ATG CGG ATC CA - 3' 
Y02  5' - AG GCT GAT TCG GTC ATT CGC CGT AAG -3' 
Y03 5' - TGG ATC CGC ATG AAC CGA ATC AGC CT - 3' 
 
Note that the labeled fluorescent dye is represented by a dot with the same color.  
The same colored sequences represent complementary pairs.  
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Table 2.2. Oligonucleotide sequences of the siRNA and Y-DNA building blocks for siRNA delivery 
Strand Sequence 
GAPDH siRNA 5' - rArArA rGrUrU rGrUrC rArUrG rGrArU rGrArC rCrUrU - 3' 
GAPDH siRNA 
(Confocal 
microscopy) 
5' - Cys 5  - rArArA rGrUrU rGrUrC rArUrG rGrArU rGrArC rCrUrU - 3' 
Bcl-2 siRNA 5' - rCrArC rArUrC rUrCrC rCrArC rArUrC rCrCrA rCrUrC rGrUrA rGrCrC rUrU - 3' 
Negative siRNA 5' - rCrCrG rUrArU rCrGrU rArArG rCrArG rUrArC rUrUrU - 3' 
Y - DNA  
(GAPDH) 
Y01 5' - /NH2/ CTT ACG GCG AAT GTC ATG CGG ATC CA - 3' 
Y02 5' - GGT CAT CCA TGA CAA CTT TAG GCT GAT TCG GTC ATT CGC CGT AAG - 3' 
Y03 5' - TGG ATC CGC ATG AAC CGA ATC AGC CT - 3' 
Y - DNA  
(Bcl-2) 
Y01 5' - /NH2/ CTT ACG GCG AAT GTC ATG CGG ATC CA - 3' 
Y02  5' - CTA CGA GTG GGA TGT GGG AGA TGT GAG GCT GAT TCG GTC ATT CGC CGT AAG - 3' 
Y03 5'- TGG ATC CGC ATG AAC CGA ATC AGC CT - 3' 
Y - DNA  
(Negative)   
Y01 5'- /NH2/ CTT ACG GCG AAT GTC ATG CGG ATC CA – 3' 
Y02  5'- AGT ACT GCT TAC GAT ACG GAG GCT GAT TCG GTC ATT CGC CGT AAG - 3' 
Y03 5'- TGG ATC CGC ATG AAC CGA ATC AGC CT - 3' 
 
Note that the labeled fluorescent dye is represented by a dot with the same color.  
The bold sequences represent complementary pairs.  
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CHPTER 3 
 
Synthetic networked DNA structures for 3D cell culture 
 
3. 1 Introduction 
In general, in vitro cell cultures conventionally refer to cells growing on a two-dimensional (2D) 
surface, a format that inhibits a number of key cellular functions (131-134). This cellular 
function impairment occurs because 2D cell culture eliminates in vivo conditions, including 
tightly bound cellular junctions between cells and their neighbors. In addition, the traditional 2D 
culture completely abolishes the interaction between cells and surrounding biological cues such 
as extracellular matrices (ECM) and growth factors (135). To date, in vitro 3D cell culture 
forming multicellular spheroids (MCS) have been widely demonstrated and applied to various 
applications ranging from fundamental cell and cancer biology to tissue engineering and 
regenerative medicine (136-140). An example of using in vitro 3D cell culture for fundamental 
studies includes the recapturing of gene expression profiles from cells that only express in 3D 
culture environments (141). Another example includes forming 3D multicellular tumor spheroids 
for ex vivo avascular solid tumor models. The avascular tumor spheroids from 3D cell culture 
simulate heterogeneity of drug diffusion gradient, intracellular adhesion junction barrier, and cell 
proliferation that could not be obtained by 2D  cell culture (142, 143). In regenerative medicine, 
3D cell cultures help promote cell differentiation of several types of stem cells. For instance, 
embryonic stem cells successfully differentiated into hepatocyte-like ultrastructures when 
cultured inside 3D collagen scaffolds, whereas the structures cannot be obtained in 2D cell 
culture (144). 
49 
 
To generate multicellular spheroids from in vitro 3D cell cultures, a number of techniques 
have been developed, including a hanging drop method, rotary orbital motion, liquid-overlay 
culture, 3D porous- and hydrogel-based scaffold (134, 145-150). One of the most widely used 
3D formation methods is the hydrogel-based scaffold. Owing to high water content (> 98%), the 
hydrogel-based method provides encapsulated cells a similar environment to physiological 
conditions.  The hydrogels can mimic characteristics such as limited gas exchange, nutrient and 
metabolic byproduct diffusion (140, 151, 152). Most conventional hydrogel-based scaffolds for 
3D culture were originally from natural products such as extracellular matrix (ECM) derivatives 
from animals and alginate derivatives from plants (153). Specifically, ECM is a mixture 
consisting of proteoglycans, proteins, and soluble factors that are essential for tissue formation 
and cellular maintenance in vivo. One of the most well-known ECM derivatives for 3D cell 
culture, referred to as a gold standard natural scaffold, is MatrigelTM, consisting of a mixture of 
laminins, type IV collagens, and heparin sulfate proteoglycans. These components render cell 
attachment to surrounding tissues (154). Additionally, plant derivatives such as alginate 
derivatives, extracted from seaweed composed of α-L-guluronic acid and β-D-mannuronic acid 
building blocks alternately connected forming linear copolymers, have been also reported as a 
scaffold alternative (155). In spite of excellent physiology-mimicking conditions for 3D cell 
culture, these natural materials adversely hinder the use in clinical studies due to several reasons. 
To begin with, natural derivative hydrogels are likely to cause immunostimulatory effects to 
animal acceptors since they are originally from different species (140). Additionaly, each batch 
of these natural derivatives varies in their components. As a result, both the biophysical and 
biochemical properties are extremely varied and uncontrolled, thereby resulting in poor 
reproducible results and therapeutic evaluation (140, 156).  
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As a consequence, the obstacles stemming from utilizing natural derivatives have inspired 
the development of synthetic materials as novel scaffolds for 3D cell culture. The synthesis of 
artificial materials should not only eliminate inconsistent and ill-defined biochemical and 
biophysical properties, but also support essential cellular behavior such as cell interaction, 
proliferation, and differentiation (149, 157). In fact, key requirements need to be achieved before 
new synthetic materials can be employed as scaffolds for 3D cell culture. First, the new synthetic 
materials have to allow adequate nutrient, gas, and waste product exchange with surrounding 
culture media for optimal cellular proliferation and function. Second, the new synthetic materials 
have to be susceptible to and degradable by cell-secreting molecules at similar rates of cell 
proliferation, migration, and reorganization to form mature multicellular structures (150, 158, 
159). Lastly, resulting byproducts emitted from the new synthetic material degradation must not 
be toxic to encapsulated cells (153). 
Thus far, a great number of synthetic materials have been developed with better controlled 
mechanical properties, chemical properties, and cell biocompatibility compared to the natural 
materials (140, 160). For instance, photocrosslinkable poly (ethylene glycol) (PEG) hydrogels 
are synthetic materials widely used as a hydrogel-based scaffold for 3D cell culture due to their 
cytocompatibility, non-immunogenicity, and antifouling property (161-163). However, chemical 
modification is required in the preparation steps of the formation of PEG hydrogels to allow 
crosslinking between PEG molecules, which is highly time-consuming (164, 165). The most 
commonly used functional groups for PEG crosslinking is an acrylate group which allows 
hydrogel formation through photopolymerization (165). After photo initiation, the PEG 
hydrogels can form with in situ cell encapsulation of cells, eliminating the need for post cell-
seeding steps (160, 166). The photo- initiated reaction of PEG-based hydrogels has effectively 
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demonstrated cell encapsulation without cellular toxicity (164, 165, 167). Although they show 
successful cell encapsulation, PEG is neither biodegradable nor bioadhesive to cells unlike 
typical extracellular matrices. As a result, embedded cells fail to maturely proliferate and arrest 
death owing to biologically inert and non-adhesive properties of the PEG-based hydrogels (149, 
168, 169). Consequently, incorporation of natural ECM has been utilized to recapture natural 
biochemical properties in the synthetic hydrogels (138, 160, 170, 171). In the case of PEG, in 
addition to cross-linking modifications,  PEG has to be modified with cell adhesion moieties and 
emzymatically sensitive signals to regain biofunctional and degradable properties (160). For 
example, fibrinogen was cross-linked on acrylate-modified PEG side chains resulting in hybrid 
PEG-based hydrogels that recapitulated cell adhesion for endothelial and smooth muscle cells 
(172). Similarly, hyaluronic-modified PEG hydrogels were also used in cartilage tissue 
engineering that aimed for enhancing cell-hydrogel interaction and enzymatically-responsive 
hydrogel degradation (173). As for synthetic peptides, several short peptide-mimicking 
fibronectin cell adhesion motifs including GRGDSP, IKVAV, and KQAGDV were commonly 
utilized to conjugate to the  PEG-based hydrogels (174-182). Other functional synthetic short 
peptides such as GPQGIAGQ, GGLGPAGGK, GPQGIWGQ, and AAAAAAAAAK have been 
also employed as enzyme-sensitive degradation motifs in the PEG-based hydrogels (133, 149, 
150, 167, 180, 182-184).  
Alternatively, purely synthetic extracellular matrix-mimicking peptide hydrogels called 
PuraMatrixTM were proposed by imitating nano and micro structures of natural ECM components 
(170, 185-187). Driven by ionic interactions between charged synthetic short peptides and ions 
in the culture media, self-assembly of fibrillar PuraMatrixTM hydrogels occurs simultaneously 
with in situ cell-encapsulation (170). The 3D cell culture by PuraMatrixTM allows encapsulated 
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cells to interact with synthetic extracellular matrix environments promoting proliferation and 
differentiation of a number of cell lines, for example neural cells, chondrocytes, and liver 
progenitor cells (188-190). Even though PuraMatrixTM has been successfully developed in 
culturing cells with synthetic extracellular matrix conditions, its degradation process is still 
problematic as the peptide sequences of PuraMatrixTM cannot be naturally degraded by available 
enzymes in vivo. 
In addition to the hydrogel-based scaffolds, biodegradable and biocompatible polyester 
porous structures have been also extensively used to support 3D cell culture such as poly lactic 
acids (PLA), poly glycolic acids (PGA), and poly lactic- co-glycolic acids (PLGA) (191-193). 
PLGA, the most popular FDA-approved polyesters, which is composed of copolymerizing of 
different ratios of PLA and PGA, can be simply degraded by hydrolysis which yields cellular 
metabolites as byproducts (191, 193, 194). Moreover, the rate of PLGA degradation can be tuned 
by controlling hydrophilic ratios between PLA and PGA (194, 195). While numerous advantages 
have been demonstrated upon using PLGA as a 3D scaffold, some concerns have also been 
raised and subsequently addressed. A major concern is the production of porous PLGA scaffolds 
which involve several chemicals and porogens resulting in harsh conditions for in situ cell 
encapsulation. Hence, a post-cell seeding method is required and causes problems in limited cell 
accessibility resulting in large void volume inside the 3D scaffold (196). Another controversial 
concern is the accumulation of metabolite byproducts that might possibly cause adverse effects 
on cell proliferation in both in vitro and in vivo (191). 
 Recently, our group has pioneered the development of self-assembled enzymatic-catalyzed 
DNA hydrogels purely made of synthetic branched DNA building blocks (70). In the report, we 
showed that the DNA hydrogels encapsulate Chinese ovary hamster (CHO) cells with cell 
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viability and active metabolic function after cell encapsulation. Additionally, the DNA hydrogels 
that were injected into B57L mice for in vivo studies did not exhibit toxicity when compared 
with PBS control. The DNA hydrogels are also easily manipulated by different endo- and exo-
nucleases (64, 70, 72). We employed the synthetic DNA hydrogels as a biocompatible and 
biodegradable scaffold for an in vitro 3D cell culture. In the study, we demonstrated that (1) the 
formation of synthetic DNA hydrogels occurred under physiological conditions and 
simultaneously encapsulate cells with high cell viability; (2) the encapsulated cells proliferated 
as a spheroidal structure inside the synthetic DNA hydrogels at least 9 days before the DNA 
hydrogel naturally degraded; (3) the flexibility of the DNA hydrogels respond to essential 
physiological cues; (4) last but not least, we demonstrated on-demand retrieval of multicellular 
spheroids (MCS) without mechanical disruption to MCS by utilizing DNase I enzymatic 
reactions. 
 
3.2 Optimization of DNA hydrogel formation for 3D cell culture 
The DNA hydrogels are synthetic materials that can be manipulated by a number of molecular 
toolkits. In addition, they are non-toxic to immobilized cells for a period of time throughout the 
in vivo study (64, 70). Branched X-DNA building blocks were prepared as reported previously 
(70). The scheme of X-DNA building blocks self-assembly and oligonucleotide sequences are 
shown in Figure 3.1 and Table 3.1, respectively. For a 3D cell culture, we first optimized the 
condition of DNA hydrogel formation to obtain the highest cell viability for in situ cell 
encapsulation. The DNA hydrogels, formed under two different ligation buffers, were incubated 
with HeLa S3 cells in the presence of 1x serum-free Optimem-I media for 6 hours. The ligation 
54 
 
conditions and their components in the optimization experiments are shown in Figure 3.2 a and b. 
Note that NEBuffer 1 buffer was supplemented with 1mM ATP throughout experiments as a 
required co-factor for a complete ligation. After incubation, cell viability was determined by 
alamarBlue reagents. The cell viability dropped dramatically to 35% and 85% after incubating 
with T4 ligase buffers and NEBuffer 1, respectively (P < 0.05). We hypothesized that high 
cellular toxicity was caused by a high concentration of dithiothreitol (DTT) supplemented in the 
T4 ligase reaction buffers. The DTT can passively diffuse through cell membrane, affecting the 
stability of disulfide bond of proteins located inside endoplasmic reticulum (ER), cell 
proliferation, and cell-cell interaction, to name a few (197, 198). We thus further investigated the 
effects of DTT concentration on cell viability by incubating cells with different concentrations of 
DTT containing serum-free media (Figure 3.2c). The results confirmed the severe cellular 
toxicity of high levels of DTT in the culture media as 10, 1, and 0.1 mM of DTT result in 29%, 
49%, and 94% cell viability, respectively (Figure 3.2c). Interestingly, compared at the same DTT 
concentrations, the cellular toxicity from ATP-containing buffers was significant lower than that 
from DTT solution alone. These results correlated with previous works that showd that after 
receiving DTT, unfolded proteins can reversibly fold back to their native structures in ATP-
supplemented conditions (198, 199). To avoid the deleterious effects of DTT to cellular 
functions, we chose NEBuffer 1 containing 1mM DTT concentration as a ligation buffer to form 
cell-encapsulating DNA hydrogels throughout the experiments. 
 
 3.3 Characterization of new condition of DNA hydrogels for 3D cell culture 
The newly adapted condition for the formation of cell-encapsulating DNA hydrogels consisted of 
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Figure 3.1. a. Schematic illustration of temperature gradient for X-shaped DNA self-assembly. b. 
Iimage demonstrating the self-assembly of the X-DNA building block in which half of each 
oligonucleotide is complementary to adjacent oligonucleotides forming X-shaped DNA. 
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Figure 3.2. The components of two ligation buffers and cell viability in different buffer 
conditions. a. The components of T4 ligase buffer provided with the T4 ligase enzyme kit and 
used to form regular DNA hydrogels in the previous publication. b. The components of 
NEBuffer 1 which is an alternative buffer for DNA ligation. c. The cell viability of HeLa cells in 
various conditions after 6 hour of incubation. Note that all conditions were prepared in 1x serum-
free media. 
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1 mM ATP-supplemented NEBuffer1 and 1x serum-free cell culture media. Next, we 
characterized major physical properties to compare with the original reported DNA hydrogels 
(70, 200). To begin with, we compared the ligation efficiency between both DNA hydrogels 
formed from both T4 ligase and NEBuffer1 buffer conditions. As the DNA T4 ligase enzymes 
have been shown to reduce their enzyme activity in the presence of NaCl higher than 150 mM, 
we investigated the activity of the DNA T4 ligase enzyme activity in the presence of typical 
culture media in the reaction (201, 202). The efficiency of X-DNA building block incorporation 
into the DNA hydrogel is used to indicate the active T4 ligase enzymes in the reaction. It was 
shown that the efficiency of X-DNA building block incorporation for T4 ligase and NEBuffer1 
buffers are 70% and 75%, respectively (Figure 3.3a). Thus, changes in ligation buffers and the 
presence of monovalent cations from the cell culture media did not inhibit the DNA T4 ligase 
enzyme activity when compared with the regular DNA hydrogels. Next, the DNA hydrogel 
swelling ratios between the two DNA hydrogel conditions were determined by weight 
differences between swollen and dried states of the DNA hydrogels (Figure 3.3b). The DNA 
hydrogels, formed according to Materials and Methods Section 3.7.1, were equilibrated with 
PBS buffer at room temperature for 24 hours. Then, excess supernatant was carefully removed 
and the weights of the swollen state of the DNA hydrogels were measured. The results 
demonstrated that the DNA hydrogels adapted from NEBuffer1 supplemented with serum-free 
cell culture media and that from the DNA T4 ligase buffers swelled 27.9-fold and 71.7-fold 
compared to their dried states, respectively. This difference in the swelling ratio is likely due to 
the fact that the presence of cationic ions such as Na+, Ca2+, and K+ is known to stabilize 
repulsive forces between negatively-charged phosphate groups on DNA backbones (10, 203, 
204). Hence, a 2.5-fold decrease in the swelling ratio of the NEBuffer1-adapted DNA hydrogels 
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compared to the regular DNA T4 ligase buffer hydrogels likely results from a higher 
concentration of mono- and multi-valent ions in the culture media presented in the DNA 
hydrogel formation. The electrostatic repulsion of the DNA hydrogel structures from the adapted 
condition was greatly reduced leading to less swelling and less hydration of the DNA hydrogels. 
As a result, we anticipated to observe smaller pore sizes from the adapted DNA hydrogels than 
those from the regular DNA hydrogels. We further investigated morphologies of the DNA 
hydrogels under a scanning electron microscope (SEM) and found that both of the DNA 
hydrogels displayed distinct porous structures (Figure 3.3c). Larger porous DNA hydrogel 
structures were obtained from the regular DNA hydrogels while smaller porous and more 
densely-packed structures were obtained from the newly-adapted DNA hydrogels. As a result, 
the decreases in the swelling ratio corresponded to changes in the DNA hydrogel microstructure, 
confirming the effects of additional mono- and multi-valent ions from serum-free media 
incorporated into the DNA hydrogels.  
 
3.4 Characterization of cell-encapsulating DNAhydrogels  
After optimizing the condition for forming in situ cell-encapsulating DNA hydrogels, various 
adherent and suspension cell lines were embedded in the DNA hydrogel to demonstrate versatile 
uses of the DNA hydrogel as a novel hydrogel-based scaffold for 3D cell culture. 
 3.4.1 Proliferation of cells encapsulated inside DNA hydrogels 
In our model study, we investigated the proliferation curve of suspension HeLa S3 cell lines after 
their encapsulation inside the DNA hydrogels. The HeLa S3 cell lines, suspension cells that were 
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Figure 3.3 Characterization of regular and adapted DNA hydrogels. a. Gel ligation efficiency of 
regular and adapted DNA hydrogels. b. Swelling ratio measured by weight differences between 
wet and dry states of regular and adapted DNA hydrogels. c. Morphological studies of freeze-
dried 0.1 mM DNA hydrogels by SEM. From left to right, (1) regular DNA hydrlgels, (2) 
adapted DNA hydrogels without serum-free cell culture media, and the adapted NEBuffer1 DNA 
hydrogels with serum-free cell culture media (working condition). (Scale bars are 20 µm) 
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mutated from anchoring-dependent HeLa cell lines, were used to represent characteristics of 
cancer cells. The HeLa S3 cells were encapsulated and evenly distributed inside the DNA 
hydrogels with high cell viability after the first hour of in situ cell encapsulation indicated by 
Calcein AM, a fluorescent dye that stains live cells (Figure 3.4a). On the fourth day of culture, 
the cells proliferated and formed loose MCS (Figure 3.4b). The proliferation rate of the HeLa S3 
cells was monitored by a dye exclusion method and total cell numbers. For the proliferation 
curve, the total cell numbers were plotted on the y-axis against culture times on the x-axis 
(Figure 3.4c). After observed for 9 days, HeLa S3 cells encapsulated inside the DNA hydrogels 
followed a typical proliferation curve, indicating normal cell functionality of the cells inside the 
DNA hydrogels. The growth of HeLa cells started reaching a plateau at day 7 with MCS 
formation. On day 9 of culture, the DNA hydrogels were completely degraded leaving all MCS 
precipitating at the bottom of the culture dishes. It is worth noting that 59% of DNA hydrogels 
remained in 10% FBS containing media (cell culture condition) after 9 days of incubation in the 
absence of cells (Figure 3.5). Therefore, the DNA hydrogel degradation was likely dependent on 
an additional presence of embedded cells that affected the surrounding environment of the DNA 
hydrogels. Subsequently, the natural degradation phenomenon of DNA hydrogels is caused by 
not only nuclease-containing serum in the cell culture media, but also the presence of the cells 
and molecules secreted from the cells encapsulated inside the hydrogels. This is very beneficial 
for extracting MCS from the DNA hydrogels for downstream applications, as MCS can be 
retrieved without any physical or chemical treatments minimizing disruption of the encapsulated 
cells.  
 3.4.2 Morphology of multicellular spheroids forming inside DNA hydrogels 
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We further investigated cell morphology after MCS were formed inside the DNA hydrogels. In 
the previous 3D proliferation study, HeLa S3 cells formed loose MCS with no spread-out 
morphology. Also, we found that the average MCS sizes enlarged as incubation times increased 
(Figure 3.6a). In addition to the HeLa S3 cell line, we also encapsulated anchorage-dependent 
cell lines including HeLa and CHO-K1 inside the DNA hydrogels and monitored their 
proliferation and morphology. Both HeLa and CHO-K1 grew and formed MCS with unique 
morphological characteristics. After six days of 3D cell encapsulation, HeLa cells formed tight 
and smooth-edged MCS while CHO-K1 cells formed grape-like MCS (Figure 3.6b and c), 
respectively. 
3.4.3 Surface functionalization of cellular recognizing signals on DNA hydrogels   
One of the most important cell behaviors when cells are cultured in synthetic materials is the 
formation of focal adhesion and their response to the surrounding environment (181, 205). In this 
study, we demonstrated the flexibility of a chemical conjugation between DNA materials and 
short peptides, which are synthetic cellular signals. For a model study, we chose to conjugate the 
3’ end of the X-DNA building blocks to a short synthetic cell-attaching signal arginine (R), 
glycine (G), and asparatate (D) (RGD) peptide. The short synthetic RGD peptide artificially 
simulates interactions between cells and extracellular matrices, thereby triggering the release of 
several intracellular signals, such as signals for cell adhesion, cell migration, and cell 
proliferation (174, 181, 206).  Hence, we incorporated the synthetic RGD peptides to one of four 
branches of the X-DNA building blocks. Specifically, we designed the system such that one 5’ 
end of the DNA oligonucleotides reacted with a decanoic acid diester linker resulting in a 
reactive N-Hydroxysuccinimide (NHS)-conjugated oligonucleotides. These NHS-functionalized 
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Figure 3.4. Cell viability and proliferation of HeLa S3 cells-encapsulated DNA hydrogels. a. Cell 
viability of HeLa S3 cells, determined by Calcein AM live staining dyes, after 6 hour and 96 
hour encapsulation. b. Proliferation curve of HeLa S3 cells cultured inside the DNA hydrogels 
for 9 days until the DNA hydrogels completely degraded.  
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Figure 3.5. Effects of 10 % fetal bovine serum (FBS) on the degradation of the DNA hydrogels 
without cells encapsulated. The remaining DNA hydrogels were investigated after 9 days by 
quantifying the total nucleotides of the DNA hydrogels left in the reactions. From left to right, 
the DNA hydrogels were incubated in 10% FBS in PBS and PBS only at 37 °C compared with 
the total X-DNA building blocks used in the hydrogel formation.   
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Figure 3.6. Mophological study of MCS cultured inside the DNA hydrogels after 6 days of the 
3D cell culture. The images were taken by confocal microscope. Three cell lines were used in the 
encapsulation experiments including HeLa S3 (a), HeLa (b), and CHO-K1 (c). F-actin filaments 
were stained with Alexa 488-conjugated phalloidin.  
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DNA oligonucleotides effectively formed a stable amide bond via the primary amines of the 
lysine amino acid (K) side chain of the RGD peptides. The N- and C- terminals of the RGD 
peptide were also capped with acetyl and primary amide groups, respectively, to protect non-
specific reactions. The conjugation reaction occurred on the oligonucleotide-supported resins 
with an excess of free synthetic RGD peptides. The NHS groups reacted with the primary amine 
groups on lysine amino acids covalently generating the RGD-conjugated DNA oligonucleotides 
linked by amide bonds. The RGD- modified and non-modified oligonucleotides were 
characterized and purified by denaturing polyacrylamide gel electrophoresis (PAGE) (Figure 
3.7a). The RGD conjugation efficiency was calculated to be approximately 60% employing 
Image J quantification. The self-assembly of the RGD-modified X-DNA building blocks was 
successfully achieved without an interference from the synthetic RGD peptides (Figure 3.7b). To 
form the RGD-modified DNA hydrogels, the RGD-modified X-DNA building blocks were 
mixed with non-modified X-DNA building blocks in different ratios and followed the protocol of 
non-modified DNA hydrogel formation. HeLa cells were encapsulated inside the RGD-modified 
DNA hydrogels with fixed concentration of the non-modified X-DNA building blocks and 
various concentrations of the RGD-modified X-DNA building blocks. The concentrations of the 
non-modified X-DNA building blocks were fixed at 120 µM and the RGD-modified X-DNA 
building blocks were 0.4 and 6.8 µM resulting in the ratios of 300:1 and 20:1, respectively. For 
both RGD-modified DNA hydrogels, HeLa cells were embedded and cultured for 4 days and 
observed under a confocal microscope (Figure 3.8a). The same tight, smooth-edged MCS that 
was previously found in the purely non-modified DNA hydrogels was also observed in the RGD-
modified DNA hydrogels. For comparison, we encapsulated HeLa cells in PuraMatrixTM, 
extracellular matrix-mimicking synthetic peptide hydrogels typically used to study cell-
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extracellular matrix interactions (151, 170, 188-190). In the experiments, a brief PuraMatrixTM 
optimization was performed and 0.15% w/v concentration was chosen to use as a model 
comparison. HeLa cells encapsulated inside PuraMatrixTM showed a spread-out morphology 
with lamellipodia and filapodial extension (Figure 3.8b). Also, the cells formed multi-layer 
structures instead of MCS, indicating a stronger interaction between cells and surrounding 
synthetic peptide hydrogels than the interaction between cells and surrounding cells that was 
observed in the DNA hydrogels. These morphological differences could be due to a number of 
factors. As previously reported, in addition to RGD densities, the changes in cellular morphology 
are also dependent on other factors including stiffness of the synthetic materials, affinity and 
spacer length between RGD signals, and cellular binding receptors (181, 207). Hence, further 
optimization is required to acquire a better understanding of the morphological changes and 
other cell-extracellular matrix interactions in the synthetic DNA hydrogels. Despite producing no 
differences on the morphological changes, the HeLa MCS exhibited higher cell growth in the 
presence of the RGD peptides at 300:1 molar ratio. Average sizes of 55.3 (± 7.80) and 70.2 (± 
11.90) µm were reported for the HeLa spheroids embedded in non-modified and RGD-modified 
DNA hydrogels, respectively. Thus, the incorporation of functional synthetic RGD peptides to 
the synthetic DNA hydrogels was seen to enhance the cell proliferation. With these results, we 
have demonstrated the potential in conjugating several short synthetic peptides to the synthetic 
DNA hydrogels for cellular response and surface functionalization.  
 
3.5 On-demand recovery of MCS by DNAse I enzymatic reaction 
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As indicated in section 3.4.1., the cell proliferation of the MCS inside the synthetic DNA 
hydrogels naturally accelerated the gel degradation, thereby leading to the release of the MCS 
without mechanical and chemical disruption to the MCS structures. Additionally, we also 
demonstrated that the MCS in the synthetic DNA hydrogels can be harvested on-demand by 
using one of the molecular toolkits associated with DNA: DNase I enzymes. HeLa cells 
encapsulated in the DNA hydrogels were cultured for 4 days and the MCS were released by 
adding DNAse I-containing culture media and incubating at 37 °C for one hour (Figure 3.9a). 
The released MCS were still intact and conserved their spheroidal shapes (Figure 3.9b). Then, 
the released MCS were simply collected by centrifuging at 100 rcf for 1 minute. The collected 
MCS were re-encapsulated inside newly prepared DNA hydrogels without causing any damages 
to the MCS structures that were observed under a confocal microscope after 24 hours of re-
encapsulation (Figure 3.9c). Moreover, the viable encapsulated MCS were fluorescently stained 
by Calcein AM (Figure 3.9d). The DNase I enzymes accelerated the degradation rates of the 
DNA hydrogel, giving the advantage of effectively releasing MCS at all stages of the 3D cell 
culture.  
 
3.6 Summary 
In conclusion, we have successfully demonstrated the use of the synthetic DNA hydrogels as a 
novel DNA hydrogel-based scaffold for 3D cell culture. The formation of the synthetic DNA 
hydrogels occurred at physiological conditions, which mean that cells can be encapsulated 
during gel formation and thereby eliminating multiple steps of cell loading. Moreover, the DNA 
hydrogels swelled approximately 28 times, forming highly porous structures in which cells are 
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able to reside and proliferate. At the same time, the porous DNA hydrogel structures are loose 
enough for nutrients and waste byproducts to be exchanged with surrounding culture media 
resulting in a typical growth curve of encapsulated cells. Additionally, the MCS grew inside both 
non-modified and RGD-modified DNA hydrogels as tight, smooth-edged MCS while the cells 
grew inside PuraMatrixTM as multi-layers in spread-out morphology. Furthermore, we confirmed 
that the functional synthetic RGD peptide conjugation led to a significant increase in the MCS 
sizes, thereby indicating higher rates of cell growth. Also, the synthetic DNA hydrogels are 
naturally and gradually degraded in a response to nuclease-containing culture media and growing 
encapsulated cells. Alternatively, the DNA hydrogels could also undergo on-demand MCS 
retrieval utilizing DNAse I enzymes. The retrieved MCS were conveniently purified and re-
encapsulated in newly formed DNA hydrogels for downstream processes with full cell function 
and high cell viability.  
 
3.7 Materials and Methods 
 3.7.1 Synthesis and Preparation of DNA hydrogels 
Synthesis of DNA hydrogel building blocks  
All DNA sequences were reported in Table 4.1. All standard DNA oligonucleotides were 
commercially synthesized from Integrated DNA Technologies, Inc (Coralville, Iowa) with 
desalting purification. An activated carboxylic acid N-hydroxysuccinimide (NHS) ester-
conjugated DNA oligonucleotides attached on supporting beads were purchased from TriLink 
BioTechnologies, Inc. (San Diego, CA). All the standard DNA oligonucleotides were dissolved  
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Figure 3.7. Characterization and purification of RGD-modified X-DNA building blocks. a. 15% 
denaturing PAGE of RGD-conjugated oligonucleotides. Lane1: oligonucleotide controls, Lane2: 
NHS-conjugated oligonucleotide controls, Lane3 and 4: RGD-conjugated oligonucleotides,  and 
Lane5: purified RGD-modified oligonucleotides. b. 3% Nusieve agarose gel electrophoresis of 
the annealing RGD-modified X-DNA building blocks. Lane1: one oligonucleotides, Lane2: two 
oligonucleotides, Lane3: three oligonucleotides, Lane4 and 5: four oligonucleotides (X-DNA 
building blocks), Lane6: RGD-modified X-DNA building blocks without purification, and Lane7: 
RGD-modified X-DNA building blocks after the purification of conjugated oligonucleotides. 
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Figure 3.8. MCS morphology of HeLa cells after 4 days of 3D cell culture by a confocal 
microscope. a. HeLa MCS encapsulated inside RGD-modified DNA hydrogels demonstrating a 
tight, smooth-edged MCS. b.HeLa cell-encapsulating PuraMatrixTM demonstrating a spread-out 
morphology with lamellipodia and filapodial extension. The scale bar is 50 µm. 
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Figure 3.9. On-demand release of MCS from DNA hydrogels. a. HeLa cells were encapsulated 
inside DNA hydrogels for 4 days. b. HeLa MCS were released from the DNA hydrogels by 
adding DNAse I enzymes for one hour. c. The released HeLa MCS were re-encapsulated inside 
the DNA hydrogels again (The image was taken after 24 hour re-encapsulation). d. The re-
encapsulated HeLa MCS were stained with Calcein AM and imaged by a confocal microscope. 
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in 10 mM Tris (pH = 8.0) in 1 mM ethylenediaminetetraacetic acid (EDTA) solution at 1 mM 
concentration. For an annealing procedure for the X-DNA building blocks, an equivalent molar 
of all 4 DNA oligonucleotides were mixed at 200 µM final concentration. The X-DNA building 
blocks were formed according to following procedures: (i) Denaturing at 95 °C for 2 min. (ii) 
Cooling at 65 °C and incubation for 5 min. (iii) Annealing at 60 °C for 2 min. (iv) Further 
annealing at 60 °C for 0.5 min with a continuous temperature decrease at a rate of 1 °C per min 
for a total of 56 cycles. The final annealed X-DNA building blocks were kept at -20°C until used. 
Design and formation of DNA hydrogels  
The standard DNA hydrogel formation protocol was reported previously (70). For the cell-
encapsulating DNA hydrogels, the standard protocol was adjusted for the cell compatibility as 
follows: Briefly, the X-DNA building blocks were mixed with NEBuffer 1, supplemented with 
1mM ATP, and DNA T4 ligase from NEB (Madison, WI) at 1x serum-free media final 
concentration. The reaction was incubated at room temperature in a sterile condition for 6 hours 
for complete enzymatic reaction. Then, the X-DNA hydrogels were washed with serum-free 
media and used for the characterization experiments of DNA hydrogels for 3D cell culture 
purpose. 
Preparation of synthetic RGD peptide and RGD-modified DNA oligonucleotide conjugates 
The synthetic short RGD peptide, Peptite 2000 was purchased from AdvancedBioMatrix, Inc 
(San Diego, CA). The lyophilized peptides were dissolved in DMSO and used immediately after 
dissolving. The NHS-conjugated oligonucleotides on supporting beads were added to RGD 
solution in DMSO and the reaction was done on a vigorous shaker at room temperature 
overnight. After the reaction, the supporting beads were pelleted, DMSO supernatant was taken 
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out, and the RGD-conjugated DNA oligonucleotides were cleaved from the supporting beads by 
adding anhydrous ammonium hydroxide at room temperature. After cleaving, the ammonium 
hydroxide was evaporated and the DNA oligonucleotides were re-dissovled in water. The 
agarose gel electrophoresis was used to characterize and purify the RGD-modifid DNA 
oligonucleotides. 
3.7.2 Characterization of DNA hydrogels 
Swelling ratio  
The effects of the presence of cell culture media to the DNA hydrogel’s properties were 
investigated by determining a swelling ratio of the DNA hydrogels. The DNA hydrogels were 
formed in the presence of 1x cell culture media final concentration as previously described in the 
DNA hydrogel formation section. Briefly, a fifty-micro liter reaction of the DNA hydrogels was 
formed in a microcentrifuge tube and incubated for 6 hours in a sterile condition.   Two hundred 
micro liters of PBS buffer were added to the gel to equilibrate the gels for 24 hours at room 
temperature. After equilibrated, the supernatant was removed from the DNA hydrogels by 
pipetting and the leftover liquid was dabbed by blotting paper on top of the gels. The DNA 
hydrogels were then weighted and lyophilized overnight with Freezone freeze dryer from 
Labconco, Inc. (Kansas City, MO) The dried DNA hydrogels were re-weighed on a scale and 
subtracted by media only dried in the tubes as a control. The experiments were done in triplicate.  
DNA hydrogel ligation efficiency  
To determine the efficiency of X-DNA building blocks incorporating into the DNA 
hydrogels, 200 µM of the DNA hydrogels were formed and incubated in 200 µL PBS buffer at 
60 °C for 24 hours in a thermocycler with 105 °C lid temperature to protect the evaporation 
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throughout the reaction. The supernatant was taken out and digested by a combination nuclease 
enzyme including DNase I, Exo I, and Exo III at 37 °C overnight to nucleotide products. The 
concentration of nucleotides was measured by Nanodrop 1000 and compared with the digested 
X-DNA building block amounts used to form the DNA hydrogels. The ligation efficiency was 
calculated as following,  
 
DNA hydrogel degradation  
The DNA hydrogels made according to section 3.7.1 were incubated with 10% serum-
containing cell culture media for 9 days at 37 °C. After incubated, the DNA hydrogels were 
washed with PBS buffer and digested to nucleotides by a combination solution of DNAse I, Exo 
I, and Exo III enzymes overnight at 37 °C. The concentration was measured by nanodrop and 
compared to initial digested total X-DNA building blocks used to form the DNA hydrogels.  
 3.7.3 Cell culture and in situ cell encapsulation inside DNA hydrogels 
Cell maintenance  
All cell lines were purchased from ATCC (Manassas, VA). All culture media and 
supplements were purchased from Mediatech, Inc. (Manassas, VA). Human cervical 
adenocarcinoma S3 cells (HeLa S3) were maintained in Kaighn's Modification of Ham's F-12 
Medium (F-12K) supplemented with 10% FBS, 100 IU/mL penicillin, and 100 µg/mL 
streptomycin. HeLa cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% FBS, 200 IU/mL penicillin, and 100 µg/mL streptomycin. Both cell 
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lines were sub-cultured in tissue culture-treated 25 cm3 flasks at 90% confluence before next-
sub-cultures and media were changed every other day.  
Cell-encapsulating DNA hydrogels  
Cells were collected by centrifuged at 1000 rpm for 5 minutes. Then, the cell culture 
supernatant was replaced by trypsin-EDTA solution (Cellgro) to disaggregate cell clusters. Cells 
were suspended at specific densities in 5uL Optimem-I serum-free media from Invitrogen 
(Carlsbad, CA). The cell suspensions in Optimem-I media were homogeneously mixed and 
immediately added to 25 µL DNA hydrogel components. The cell-encapsulating DNA hydrogels 
were incubated for complete ligation at room temperature for 3 hours in a sterile condition. After 
formed, the cell-encapsulating DNA hydrogels were cultured in the full culture media (10% FBS 
containing F-12K media) in a humidified incubator at 37 °C and 5% CO2 level.  
3.7.4 In vitro characterization of cell-encapsulated DNAhydrogels  
Cell toxicity  
To determine biocompability of the DNA hydrogel formation, cells were plated at 12,000 
cells per well in 96-well plate overnight before the experiment. Different conditions for the DNA 
hydrogel formation were mixed with 1x serum-free media final reaction volume. After incubated 
for 6 hours, cells were washed with PBS buffer and replenished with 10% FBS containing cell 
culture media and continued incubation for 48 hours. Next, cells were washed with serum-free 
media, replaced by 10% containing alamarBlue reagent, and incubated at 37 °C for 6 hours. The 
cell supernatant was transferred to a black 96-well plate for fluorescence reading at excitation 
and emission wavelength 560 and 590 nm, respectively, using a Synergy 4 microplate reader 
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(Winooski, VT). Serial dilution of cells was performed as a standard curve for each specific 
incubation time. 
Cell proliferation  
Total cell numbers were consequently counted after alamarBlue measurement at specific 
time points. Cell culture media was removed and the cell-encapsulating DNA hydrogels were 
disrupted by pipetting and trypsin-EDTA solution was incubated for 5-10 minutes to 
disaggregate the MCS. Total numbers of single cells were determined by the dye exclusion 
method.  
Metabolic activities  
At specific time points, cell culture media was removed and the cell-encapsulating DNA 
hydrogels were disrupted by pipetting and trypsin-EDTA solution was incubated with the MCS 
for 5-10 minutes. One equal volume of alamarBlue reagent was added and incubated for 1-4 
hours at 37 °C depending on cell density conditions. After incubation, the cell suspension was 
centrifuged and the supernatant was transferred to a black 96-well plate for fluorescence reading 
at excitation and emission wavelength 560 and 590 nm, respectively, using a Synergy4 
microplate reader (Winooski, VT). Serial dilution of cells was performed as a standard curve for 
each specific incubation times. 
On-demand recovery of MCS from DNA hydrogels  
After the MCS were cultured up to desired time points, cell culture media was replaced by 30 
µl of DNase I buffer adapted for cell culture at 37 °C for 60 minutes. The buffer consists of 1 µl 
DNase I enzymes (2 units/µl) (Madison, WI) supplemented with  0.5 mM Ca2+ and 2.5 mM 
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Mg2+ in serum-free culture media. The released MCS were centrifuged at 200 rcf for 1 minute, 
separated from the supernatant and resuspended in cell culture media, and transferred to a 96-
well plate. The reattachment of cell spheroids was observed after 6 hours by a confocal 
microscope. 
 3.7.5 Microscopic analysis 
Scanning electron microscope (SEM)  
All DNA hydrogel conditions were studied by SEM. First, the DNA hydrogels were formed 
and incubated at room temperature overnight. Then, the DNA hydrogels were washed with water 
to remove excess salt residue. Next, the DNA hydrogels were frozen by immersion  in liquid 
nitrogen, and then freeze-dried by Labconco lyophilizer overnight. The lyophilized DNA 
hydrogels were immobilized on the stub and coated with gold nanoparticles. The samples were 
observed by LEO 1550 FESEM. 
Fluorescence confocal microscope  
The cells-encapsulating DNA hydrogels were washed with PBS buffer, fixed with 4% 
paraformaldehyde for 2 hours at room temperature, permeabilized with TBP solutions containing 
1% Triton-X, 2% BSA in PBS solution for 1 hour, stained with phaloidin Alexa 488 conjugated 
proteins from Invitrogen (Carlsbad, CA), and then washed with PBS buffer. The cells-
encapsulating DNA hydrogels in PBS buffer were sealed with cover glass slip on a chamber 
slide and 20 x or 40 x magnifications of oil immersion objective lens were used to capture 2D 
and 3D images using an upright Zeiss LSM 510 Meta confocal microscope. 
Image analysis  
78 
 
To measure the size of MCS, images from a confocal microscope under 20x magnifications 
were used to determine the average sizes. The sizes of MCS were obtained by measurement of 
the pixel numbers of lines drawn crossing the spheroids followed by conversion to actual lengths 
using Image J (NIH). For irregular shapes of MCS, multiples crossing lines were drawn in 
directions to reflect the varied diameter of the spheroids, and the mean value of these 
measurements was used to characterize the spheroid size. The total MCS of 19 were used in the 
analysis. 
3.7.6 Statistical analysis 
Statistical analysis was performed using One-way ANOVA. Statistical significance was assigned 
for two-tailed 95% confidence. All experiments were conducted three times and results were 
reported as mean ± SD. 
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Table 3.1 Oligonucleotide sequences of regular and modified X-DNA building blocks for the 
DNA hydrogels 
Strand 5’ 
palindromic 
segment 
Core segment 3’segment 
X1 Regular 5’-p-ACGT CGACCGATGAATAGCGGTCAGATCCGTACCTAC TCG-3’ 
X2 Regular 5’-p-ACGT  
CGAGTAGGTACGGATCTGCGTATTGCGAACGAC 
 
TCG-3’ 
NHS 5’-  
X3 Regular 5’-p-ACGT  
CGAGTCGTTCGCAATACGGCTGTACGTATGGTC 
TCG-3’ 
X4 Regular 5’-p-ACGT CGAGACCATACGTACAGCACCGCTATTCATCGG TCG-3’ 
 
Note that 1. p represents the phosphorylation on the 5’ end of the oligonucleotide. 
                 2. Regular represents the previously reported X-DNA sequences. 
                 3. NHS represents the modified activated NHS ester oligonucleotide sequence. 
                 4. Hybrid (12) and (20) represent the oligonucleotide sequence with extended 
                    (12 and/or 20) nucleotides for RNA/DNA hybridization 
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CHAPTER 4 
Synthetic networked DNA structures for siRNA controlled release and 3D siRNA delivery 
 
4.1 Introduction 
RNA interference (RNAi) is an innate post-transcriptional mechanism that has rapidly developed 
as an alternative method for inhibiting a number of human disease mechanisms at a mRNA level 
and for investigating gene functions (114). The mechanism of the RNAi inhibition involves in 
short single-stranded RNA nucleotides called small interference RNA molecules (siRNA) that 
are specifically complementary to genes of interest. SiRNA typically consists of 19-22 RNA 
base pairs with 2 nucleotide overhangs at 3’ end at both ends (114). In the process occurring in a 
cytoplsm, the siRNA induces the assembly of the RNA-induced silencing complex (RISC) in 
which the antisense siRNA strand is incorporated and bound to the complementary mRNA target 
(208). After binding, the RISC silences gene expression by degrading the mRNA and departs 
from the complex to find a new target. The process is recycled, thus repeatedly downregulating 
gene expression with only a small amount of siRNA. Unfortunately, the process is transient due 
to the fact that the siRNA does not integrate into genomic DNA. Hence, cell proliferation 
alleviates the efficiency of the silencing. As a consequence, multiple treatments are required to 
maintain effective therapeutic levels. Also, the siRNA cannot passively penetrate cell 
membranes resulting in a need in carriers to circumvent this issue. As a result, a number of 
synthetic carriers and delivering methods have been purposed to efficiently carry the siRNA into 
the targeted cells.   
 Early synthetic carriers for siRNA delivery are fundamentally transferred from DNA delivery. 
However, several obstacles have been presented from adopting DNA delivery to siRNA delivery 
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(209). In spite of being classified as nucleic acids, in fact, siRNA have several distinct 
characteristics to DNA. The shorter length of siRNA causing lower negative charge ratios forms 
weakly cationic complexes when mixed with the typical transfection reagents (209). In addition, 
the presence of oxy-ribose rings giving the RNA more prone to several enzymatic reactions. 
Furthermore, unlike circular DNA, the small size of siRNA molecules prevents them from 
physically being entrapped inside scaffolds for sustained and controlled release (210). 
 So far, many cationic siRNA transfection reagents have been reported and are one of the 
most widely used siRNA carriers. The cationic transfection reagents can be made of several 
materials, for example, liposomes, polyamines, and synthetic cationic polymers. However, the 
cationic tranfection reagents are reported to be highly toxic to cells and massive cell death. 
Neutral and anionic transfection reagents have also been purposed but reported to have lower 
tranfection efficiency. Alternatively, a transfection of circular DNA molecules expressing short 
hairpin RNA molecules (shRNA) which are processed to siRNA by Dicer was purposed to 
overcome the transient gene silencing issue (211, 212). Nevertheless, those direct siRNA 
delivery methods are simpler than indirect shRNA transcribed from the circular DNA 
transfection delivery as the direct delivered siRNA can promptly function in the cytoplasm after 
reaching the cell targets without the need of nuclear transportation.  
 Consequently, a lot of effort has put in order to improving the current direct siRNA delivery 
(114). First, several novel carriers have been generated to efficiently deliver siRNA into the 
targeted cells. Lipid platforms typically incorporate siRNA either by encapsulation within the 
hollow aqueous cores of lipid-based shells known as liposomes and/or by formation of electro-
static complexes called lipoplexes. Lipoplexes have been widely used for its high transfection 
efficiency and ease of formation: nanocarriers can be generated simply upon a simple mixing of 
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lipids and siRNA at stoichiometric ratios. However, nonpermanent electrostatic interactions can 
make lipoplexes unstable. Thus, lipoplexes usually have a short shelf-life and often need to be 
prepared immediately prior to the transfection (213). In addition to lipids, synthetic polymers 
have been shown to effectively delivery siRNA due to their ability to readily complex with 
anionic siRNA molecules and also to induce endosomal escape into the cytosol. One of the most 
notable cationic synthetic polymers is polyethylenimine (PEI). PEI is a highly positively-charged 
polymer containing tertiary amines that has been established to facilitate endosomal escape via 
the proton sponge effect (214). Recently, Lee et al. has used PEI to form siRNA microsponge 
complexes and delivery them in vivo (108).  
 Second, the improvement of targeting delivery has been clearly increased the efficiency of 
the siRNA delivery (106, 215, 216). The cell-targeted siRNA delivery has proven tremendously 
beneficial to therapeutic applications such that the targeting delivery aiming only at silencing 
abnormal protein-transcribed mRNA surrounded by normally functional mRNA in the cells 
eliminating off-target effects to non-related or normal cells. As a consequence, several targeting 
molecules that specifically bind to specific cell-surface signals or receptors have been physically 
or chemically attached to the siRNA platforms. The targeting molecules are such as receptor- 
binding proteins, antibodies, cell- specific short peptides and nucleic acids (175, 183). Not only 
decreasing off-target effects, some of the targeting molecules can enhance the overall efficiency 
of the siRNA by increasing the cellular uptake of the siRNA into cells. (215-217). Moreover, 
some targeting molecules can directly conjugate to siRNA and simultaneously delivery the 
siRNA into the cells. These molecules are including cholesterols, short peptides, DNA and RNA 
aptamers (183, 216).  
 Third, the development of siRNA carriers that can control siRNA encapsulation and trigger a 
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controlled release of siRNA has been also gaining interests. Currently the release of siRNA is 
purely relying on diffusion based on a pore size, charge of materials, and material degradation 
(218-222). Thus, having the siRNA platforms in which the release of encapsulated siRNA can be 
controlled and timely triggered make the siRNA delivery more efficient and beneficial to in vivo 
studies. To encapsulate the siRNA for a controlled release study, a number of methods has been 
demonstrated such as physical entrapment, electrostatic interaction, and chemical conjugation 
(223-226). Most of the current siRNA controlled release platforms are only applicable to 
conventional 2D cell culture studies (222, 224-229). Also, most of these siRNA controlled 
release platforms are governed by diffusion-based method, not time-specific controlled. NIR-
triggering siRNA nanoparticles are one of very rare platforms inducing the releases of siRNA 
upon request (224). Another triggered release of siRNA was performed by conjugating siRNA to 
the hydrogels employing disulfide linkages. The siRNA was released from the hydrogels in the 
reducing environment inside cells (226). 
 Even though, 3D cell culture systems have been greatly developed as ex vivo conditions, the 
siRNA delivery in 3D cell culture constructs do not improve fast enough to gain effective 3D 
siRNA delivery. The results from delivering siRNA to 3D cell constructs or MCS were always 
low at the siRNA delivery efficiency. This is due to the fact that the MCS consisting of tight 
adhesive junctions can block cells growing inside from exposing to siRNA. One way to solve the 
3D gene delivery issue that was previously reported in DNA delivery of the MCS was to first 
transfect cells in monolayers and then reform the monolayer transfected cells into MCS (230). 
Even if the process was a success, two separate cell-handling procedures were required to 
achieve the 3D transfection which is only applicable for few samples. High throughput studies 
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are not possible with this current procedure. Thus, there are great challenges for achieving an 
effectively time-specific controlled release of siRNA delivery in 3D cell culture (175, 183).   
 Here, we proposed a novel platform for time-specific and controlled release of siRNA in 
which the siRNA simply tethered by hybridization to the DNA hydrogels without further 
modifications. The siRNA-hybridizing DNA hydrogels (siRNA hydrogels) acted as a siRNA 
reservoir that can control the release of siRNA with distinct releasing rates. The differences in 
siRNA releasing rates from the siRNA hydrogels were dependent on the amount of RNase H 
enzymes in the environments. In addition, we demonstrated a potential to combine the 3D cell 
culture and siRNA delivery as a two-in-one 3D siRNA delivery platform where only one step 
needed to simultaneously form 3D cell structures and tether siRNA inside the siRNA hydrogels.  
 
4.2 Design and Concepts of siRNA-DNA and c1-siRNA-DNA chimera hydrogels 
We tethered siRNA molecules inside the DNA hydrogels simply by hybridizing the siRNA to 
complementarily designed DNA sequences on X-DNA building blocks (X-siRNA) without any 
modifications. Specifically, one of four X-DNA’s palindromic sticky ends was sacrificed and 
replaced with a 12-nucleotide non-palindromic overhang that was previously reported to stably 
hybridize between Y-DNA building blocks and form networked DNA structures under 
physiological conditions (64). As for the design of modified siRNA, the 3’ end of sense siRNA 
strand was extended with the complementary sequences of that 12-nucleotide overhang and 5-
nucleotide spacer (Figure 4.1a). Thus, the hybridization of siRNA to X-DNA building blocks 
generated RNA/DNA hybrids which were used to control the release of siRNA. The RNA/DNA 
hybrids were precisely controlled by the endonuclease RNase H-triggered enzymatic reaction as 
the endonuclease RNase H enzyme only degrades RNA oligonucleotides hybridizing to its 
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complementary DNA sequences (Figure 4.1b). By adding RNase H, the RNA nucleotides on 
RNA/DNA hybrid structure were degraded releasing the siRNA from the siRNA hydrogels 
(Figure 4.1d). The siRNA releasing system was accomplished without destructing the cultured 
MCS and DNA hydrogel structures. The time-specific controlled release of siRNA from the 
siRNA hydrogels was done by varying the amount of RNase H presented in the siRNA 
hydrogels’ environment. We further demonstrated a potential in using our siRNA hydrogels for a 
two-in-one 3D siRNA delivery platform where only one step needed to simultaneously form 3D 
cell structures and tether ready-to-transfect siRNA inside the siRNA hydrogels. In our two-in-
one siRNA hydrogel platform, we utilized c1 RNA aptamers that can enhance cellular uptake 
instead of transfection reagents as the whole process can be done in one step (97). The c1 RNA 
aptamer has been previously reported to enhance the cellular uptake in various cells such as 
human cervical (HeLa), mouse pancreas (Min 6B1), and mouse endothelial (Bend3) (97). The c1 
aptamer was rationally designed to be on the 5’ of the sense siRNA strand (Figure 4.1c). Also, 
we employed chemically 2’ fluorine- modified cytidines (2’F-C) and 2’ fluorine-modified 
uridines (2’F-U) for a nuclease resistance. In this case, we redesigned the RNA/DNA hybrid 
sequences to be a long 20-nucleotide adenine sequences (A20) on the RNA strand and 20-
nucleotide thymine sequences (T20) on the sacrificed end of X-DNA building block, respectively 
(X-c1-siRNA). Like the previously controlled release, RNase H digests the (A-T20) RNA/DNA 
hybrids, releasing c1-siRNA chimeras from c1-siRNA hydrogels into the environment. The 
newly formed MCS can thus uptake the c1-siRNA chimeras after the gels are triggered with 
RNase H. RNase H remarkably does not interrupt the MCS residing inside the hydrogels 
resulting in a continuous proliferation after the RNase H treatment.   
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Figure 4.1. Schemes illustrating the siRNA-encapsulating DNA hydrogels. a. a X-siRNA 
building block consisted of four DNA oligonucleotides and two siRNA ribonucleotides.  b. The 
X-siRNA digested by RNase H resulting in X-hybrid and released siRNA where the RNA hybrid 
were digested by RNase H. c. The X-c1-siRNA building block modified from X-siRNA with 
addition of c1 aptamer at the 5’ end of the sense siRNA d. an experimental scheme of the siRNA 
hydrogels in the presence of RNase H enzymes representing RNase H-digesting siRNA 
hydrogels.  
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4.3 Fabrication and Characterization of X-siRNA, X-c1-siRNA building blocks and siRNA 
and c1-siRNA hydrogels 
The X-siRNA building block was self-assembled with the same protocol of the X-DNA building 
block. The X-siRNA building block consists of four DNA oligonucleotides and two RNA 
oligonucleotides for X-DNA and siRNA, respectively. The self-assembly of X-siRNA was 
confirmed on 5% nusieve agarose gel electrophoresis (Figure 4.2a). From a titration experiment, 
the efficiency of self-assembled X-siRNA was 51.3% (±1.41%) calculated by band intensity 
from Image J. We have tested different molar ratios between X-DNA and siRNA by increasing 
the siRNA to 4 equivalents higher than the ratio of X-DNA. However, the efficiency of X-
siRNA self-assembly did not give a better annealing result. This is very likely due to the short 5 
nucletide spacers causing a steric hindrance and repulsive force between siRNA and X-DNA. As 
shown in figure 4.2a, the hybridization at 1:1 equivalent of sense and antisense siRNA strands, 
self-assembly of X-DNA, and X-DNA with extended sequences for hybrid hybridization (X-
hybrid) on lane1,2, and 3, respectively gave only one major band meaning 100% successful 
annealing. On lane 4, the sense siRNA strand and X-hybrid annealed at 1:1 equivalent molar 
showed two major bands consisting of hybridized to the X-hybrid-sense-siRNA and X-hybrid 
representing a reduce in annealing efficiency of X-hybrid-sense-siRNA  than X-hybrid alone. 
After the antisense siRNA strands were added (lane 5), two major products were obtained where 
the upper band showing the successful incorporation of antisense siRNA forming a X-siRNA 
building block and the lower band corresponded to the X-hybrid. Thus, we conclude that the 
limiting step of self-assembling X-siRNA was due to the hybridization of RNA and DNA hybrid. 
We further investigated the digestion of RNA/DNA hybrid on X-siRNA in the presence of 
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RNase H (Figure 4.2b). Within 30 minutes, the X-siRNA building blocks were completely 
digested resulting in X-hybrid (upper band) and digested siRNA (lower band). 
To form the siRNA hydrogels, X-siRNA and X-DNA building blocks were mixed and 
ligated by adding T4 ligse enzymes. The efficiency of siRNA tethered inside the siRNA 
hydrogels was approximately at 1:50 mixing ratio of X-siRNA and X-DNA building blocks, 
respectively. The measurement was determined by fluorescence reading of fluorescein-
conjugated antisense siRNA (FAM-antisense siRNA) of non-ligated X-siRNA building blocks 
after two days of washing with PBS buffer (Figure 4.3a). The encapsulation efficiency of siRNA 
was approximately 25% (±3.10%) at 1:50 mixing ratio of X-siRNA and X-DNA building blocks, 
respectively.  
For the self-assembly of X-c1-siRNA building block, the modified c1-sense RNA strand was 
synthesized from in vitro transcription with 2’F-U and 2’F-C nucleotides incorporated to protect 
the RNA from nuclease degradation. The modified C1 RNA transcript hybridized to antisense 
siRNA forming c1-siRNA chimeras (Figure 4.3a). In order to preliminarily test the nuclease 
resistance of modified c1 RNA transcripts and c1-siRNA chimeras, both structures were 
incubated with 10% FBS containing media at 37 °C for 24 hours. Then, the samples were run on 
9% native PAGE (Figure 4.3a). The modified c1-siRNA duplexes showed the integrity of siRNA 
representing one major band on the gel. As for non-modified c1 RNA transcripts, the RNA 
degraded within 24 hours after incubating with 10% FBS in media at 37 °C. For the X-c1-siRNA 
builing blocks, we started the self-assembly with 2.5 equivalents of modified c1-sense RNA 
transcripts to 1 equivalent of the X-hybrid and antisense-siRNA. The self-assembly of X-c1-
siRNA building blocks were shown on 9% native PAGE (Figure 4.3b). Based on the gel image, 
only one product was obtained from the X-c1-siRNA self-assembly, representing 100% ligation 
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Figure 4.2. Characterization of X-siRNA on 5% nusieve agrose gel electrophoresis, ran at 4 °C 
with 0.5x TBE buffer, stained with gel red for 1 hour. a. Self-assembly of X-siRNA components. 
From left to right:  siRNA duplexes with hybridization sequence on the sense siRNA strand, self-
assembly of the X-DNA building block, self-assembly of the X-hybrid alone, self-assembly of 
X-hybrid and sense siRNA strand, and self-assembly of X-siRNA building block yielding two 
major products; X-DNA and X-siRNA. b. RNas H digestion of X-siRNA. From left to right: X-
siRNA control at room temperature, X-siRNA control incubated at 37 °C for 30 minutes, and X-
siRNA incubated with RNase H at 37 °C for 30 minutes. 
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efficiency of the X-c1-siRNA building block. The better annealing efficiency compared with the 
X-siRNA building block could be explained by the extension of hybridzation sequences which 
gave more flexibility and reduced the steric hindrance between the X-hybrid and c1-siRNA 
duplexes. Also, the X-c1-siRNA building blocks were tested for Rnas H digestion (Figure 4.3b, 
lane4). The RNase H-digesting X-c1-siRNA building blocks resulting in the X-hybrids and 
digested c1-siRNA chimeras. For nuclease degradation test, the X-c1-siRNA building blocks 
were incubated with 10% FBS containing media at 37 °C for 24 hours and the samples were run 
on the native PAGE to check the integrity of the structures (Figure 4.3c). The X-c1-siRNA 
building blocks were not degraded in the presence of 10% FBS over 24 hours. In addition, the 
RNase H digested the RNA/DNA hybrid sequences giving the complete c1-siRNA chimeras as 
the products. Once the X-c1-siRNA building blocks were incorporated into DNA hydrogels (c1-
siRNA hydrogels), the incorporated siRNA efficiency was quantified by measuring FAM-
conjugated antisense siRNA representing X-c1-siRNA in the supernatant. Unfortunately, the 
siRNA encapsulation efficiency greatly reduced as the amount of ligated X-c1-siRNA building 
blocks was only 10% (±3.04%).  
 
4.4 Time-specific controlled release of siRNA from the siRNA hydrogels by RNase H 
FAM-conjugated siRNA duplexes were released from the siRNA hydrogels after the gels were 
treated with an excess amount of RNase H. The siRNA-encapsulated DNA hydrogels before 
were shown in figure 4.4a. Two sets of siRNA hydrogels were treated with RNase H at 28 and 
76 hours after incubation, respectively. We observed two sharp increases in siRNA cumulative 
release profiles within 30 minutes of the RNase H digestion (Figure 4.4b). This confirms the- 
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Figure 4.3. Characterization of X-siRNA and X-c1-siRNA building blocks by 9% native PAGE. 
a. Characterization of the modified c1 RNA transcript, hybridization test of the c1-siRNA 
chimeras, and 10% FBS degradation test. Lane 1, 3, and 5 are the modified c1 RNA transcripts, 
the c1-siRNA chimeras, and non-modifed c1 RNA transcripts, respectively. Lane 2,4, and 6 are 
the same samples according to lane 1,3, and 5 but were incubated with 10% FBS containing 
media  at 37 °C for 24 hours. 
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Figure 4.3 (continued) Characterization of X-siRNA and X-c1-siRNA building blocks by 9% 
native PAGE. b. RNase H digestion of X-c1-siRNA building blocks. From left to right, X-hybrid, 
X-c1-siRNA, c1-siRNA chimeras, and X-c1-siRNA in the presence of RNase H. The digested 
c1-siRNA chimeras were released from the X-c1-siRNA building blocks after treating with 
RNase H. 
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Figure 4.3 (continued) Characterization of X-siRNA and X-c1-siRNA building blocks by 9% 
native PAGE. c. Serum resistance of and RNase H activity in the presence of serum after 24 
hours. Lane 1,3, and 5 are the X-c1-siRNA, X-c1-siRNA treated with Rnase H, and X-hybrid 
building blocks. Lane 2,4,and 6 are the same sample of lane 1,3, and 5 but were incubated with 
10% FBS containing media. Note that the RNase H treatments were done after 24 hour 
incubation. 
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time-specific releases of siRNA from the siRNA hydrogels.  
 In addition to time-specific releases of the siRNA, we also performed series of siRNA 
controlled release profiles by controlling the amount of RNase H presented in the environment. 
The cumulative release of siRNA from three different RNase H amounts led to three distinct 
kinetic release profiles of siRNA (Figure 4.4c). Twenty units of RNase H resulted in 50% siRNA 
released within the first hour. Slower cumulative siRNA release profiles were obtained when less 
RNase H was presented in the environment. When the gels were treated with 0.5 and 0.125 unit 
of RNase H, 50% of the siRNA were released within 5 and 7 hours, respectively. Further 
optimization of the siRNA release rates is required for an optimal siRNA silencing. 
 The functional test of released siRNA was conducted by investigating a gene silencing of 
GAPDH mRNA in HeLa S3 cell lines. The GAPDH siRNA hydrogels were treated with 40 units 
of RNase H for one hour and the GAPDH siRNA-containing supernatant was collected. The 
RNase H-treated GAPDH siRNA formed complexes by mixing with commercial polyamine 
transfection reagents (siPORT Amine) and was transfected into pre-plated HeLa S3. The 
GAPDH silencing efficiency after 48 hour post-transfection was tested at 100, 150, and 200 nM 
siRNA concentrations after the siRNA hydrogels were treating with RNaseH (Figure 4.5). The 
remaining GAPDH proteins were tested for its functions and the results showed that 
approximately 45-55% of GAPDH proteins were silenced by the siRNA digested from siRNA 
hydrogels. Compared with commercial siRNA, our released siRNA showed comparable 
silencing effects. This enlightened us that the presence of RNase H and its digestion did not 
interfere with the functionality of the released siRNA.   
 
95 
 
 
Figure 4.4. SiRNA-encapsulating DNA hydrogels, time-specific, and controlled siRNA release 
profiles a. The siRNA hydrogels (left tube) and the DNA hydrogels (right tube) after two days of 
washing imaging by Kodak imaging system. The siRNA hydrogels showed flurescence of FAM-
conjugated siRNA tethered inside the DNA hydrogels. b. The time-specific controlled release 
profiles of the siRNA hydrogels after specifically adding RNAse H at 28 and 76 hours after 
incubation in PBS at 37 °, respectively. 
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Figure 4.4 SiRNA-encapsulating DNA hydrogels, time-specific, and controlled siRNA release 
profiles (continued). c. The series of siRNA controlled release profiles of the siRNA hydrogels 
after adding various amounts of RNase H; 20, 0.5, and 0.125 units, respectively.  
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Figure 4.5. Remaining GAPDH protein activity 48 hour post-siRNA transfection. From left to 
right, 150 nM commercial GAPDH siRNA control, siRNA duplexes before hybridizing to X-
siRNA building blocks, 100, 150, and 200 nM of the released siRNA from RNase H-digesting 
siRNA hydrogels, and 150 nM scramble negative siRNA control.  All samples except released 
siRNA 150 nM are significantly different from the negative siRNA control at (P < 0.05). 
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4.5 A two-in-one c1-siRNA hydrogel platform for 3D siRNA delivery 
In order to gain more advantages of our developed siRNA hydrogels, we created the two-in-one 
c1-siRNA hydrogel platform that simultaneously deliver siRNA to newly formed and/or forming 
MCS within one step. Also, our 3D siRNA delivery platform employs a cellular-enhancing 
uptake RNA aptamer instead of forming siRNA complexes with any external transfection 
reagents. As we demonstrated that the X-c1-siRNA and X-DNA building blocks are stable and 
not degraded in serum-containing media, we next perform the cell-encapsulating c1-siRNA 
hydrogels.  
For 3D siRNA delivery, we began to investigate the cellular uptake of RNase H-treated 
siRNA released from X-c1-siRNA building blocks to a 2D conventional method. The Z-sliced 
images from a confocal microscope displayed c1-siRNA chimeras suggesting the c1 aptamers 
were still active in enhancing the cellular uptake after the RNase H treatment (Figure 4.6a-b). 
Next, HeLa cells were encapsulated inside the c1-siRNA hydrogels for 72 hours and an excess 
amount of RNase H was added to trigger the release of c1-siRNA chimeras. Based on Z-sliced 
images, HeLa MCS were formed inside the c1-siRNA hydrogels with heterogeneous uptakes of 
released siRNA chimeras in different location including outer and inner cells of the spheroids 
(Figure 4.6c). However, the MCS from non-treated RNase H siRNA hydrogels were also 
observed the siRNA. This might due to the non-ligated X-c1-siRNA inside the hydrogels. 
However, based on the preliminary results, we hope to be able to improve and establish the 
simple and efficient platform for the 3D siRNA delivery.  
 
4.6 Summary 
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Figure 4.6. Z-stack confocal microscope images of FAM-labelled c1-siRNA chimeras 
transfecting HeLa cell lines. a. The 2D conventional uptake of cell only and b. released c1-
siRNA chimeras. The cells were imaged by employing a 40x objective lens in oil. c. HeLa MCS 
grown inside the c1-siRNA hydrogels for 72 hours were treated with RNase H for 6 hours before 
imaging by compiling  z-stack images. Nuclei were stained by DAPI (blue) and F-actin filaments 
were stained by rhodamine-labeled phalloidins (red).  
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In general, siRNA are very difficult to be encapsulated inside a scaffold without further 
modifications because of their small size and low negative charge per molecules. Here, we have 
successfully demonstrated the use of the DNA hydrogels to encapsulating the siRNA utilizing 
hybridization, the inherent property of nucleic acids. Thus, the DNA hydrogels tether the siRNA 
without further chemical conjugation. As a result, the siRNA were encapsulated inside the DNA 
hydrogel and the time-specific siRNA releases were occurred by adding RNase H. Also, we 
demonstrated the series of siRNA controlled release profiles by controlling the amount of RNase 
H in the environment. The siRNA encapsulating efficiency was approximately 30%. The 
released siRNA formed cationic complexes with transfection reagents and inhibited the protein 
function without loss of siRNA activity. Furthermore, we developed the two-in-one c1-siRNA 
hydrogel platform for 3D siRNA delivery application by combining the time-specific release of 
siRNA to the formation of MCS inside the DNA hydrogels. We were able to deliver siRNA to 
newly formed MCS and hoped to use the two-in-one c1-siRNA hydrogel platform to improve the 
siRNA delivery for MCS. 
 
4.7 Materials and Methods 
4.7.1 Materials  
All DNA and RNA oligonucleotides were commercially synthesized from Integrated DNA 
Technologies, Inc (Coralville, Iowa) and used without further purification. All enzymes were 
purchased from New England Biolab, Inc. (Madison, WI). Nusieve agarose powder was 
purchased from Lonza Group Ltd. (Basel, Switzerland). All cell lines were purchased from 
ATCC (Manessas, VA). All culture media and supplements were purchased from Mediatech, Inc.  
(Manessas, VA). The Optimem-I media was bought from Life Technologies (Grand Island, NY). 
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The DuraScribe® T7 transcription kits was purchased from Epicentre Biotechnologies (Madison, 
WI). Gel red was bought from Biotium Inc. (Hayward, CA). All chemicals were purchased from 
Sigma-Aldrich (St. Louis, MO) or otherwise indicated. 
4.7.2 Synthesis, preparation of siRNA hydrogels and c1-siRNA hydrogels 
Synthesis of X-siRNA and X-c1-siRNA building blocks  
The DNA and RNA sequences in the experiments are reported in Table4.1. All DNA 
oligonucleotides were dissolved in TE buffer containing 10 mM Tris, 1 mM 
ethylenediaminetetraacetic acid (EDTA) solution (pH = 8.0). All RNA oligonucleotides were 
dissolved in nuclease-free (DEPC-treated) water at 1 mM concentration. For a X-siRNA building 
block annealing, four equivalent molars of the hybrid sense and antisense siRNA was mixed with 
one molar equivalent of all four X-DNA oligonucleotides (X1, X2, Xhybrid(12), and X4) at a final 
concentration of 50 µM X-DNA concentration. For a X-c1-siRNA building block, two and a half 
molar equivalents of c1-sense siRNA strands were mixed with one molar equivalent of all 4 X-
DNA oligonucleotides (X1, X2, Xhybrid(20), and X4) and antisense siRNA strands at a final 
concentration of 50 µM X-DNA concentration.  
In vitro transcription of modified c1 RNA aptamers  
The modified c1-aptamer DNA templates were annealed in TE buufer containing 10 mM 
Tris (pH=8.0) in 1 mM ethylenediaminetetraacetic acid (EDTA) solution at 10 µM concentration 
with the same X-DNA building block protocol. One µg of modified c1-aptamer DNA template 
was used per one in vitro transcribtion. The reaction was done at 37 °C overnight and treated 
with DNAse I (NEB) to degrade the DNA templates. Then, the modified c1 RNA transcript 
products were purified by Microcon® centrifugal filters (Ultracel- 10 Membrane) (Billerica, MA) 
and used for the self-assembly of the X-c1-siRNA building blocks.  
102 
 
Formation of siRNA and cell-encapsulating c1-siRNA hydrogels  
For the siRNA hydrogels, X-DNA and X-siRNA building blocks were mixed in 25:1 or 50:1 
ratio, respectively. The hydrogel formation was followed the materials and methods in section 
3.7. After forming, the siRNA hydrogels were incubated at room temperature for 5 hours and 
washed with PBS buffer overnight at 37 °C. For cells-encapsulating c1-siRNA hydrogels, X-
DNA and X-c1-siRNA building blocks at 25:1 ratio (100:4 µM) were simultaneously mixed with 
HeLa cells suspended in Optimem-I media and formed the hydrogel according to the previously 
reported protocol in section 3.7. The cell-encapsulating c1-siRNA hydrogels (cell-siRNAgels) 
were incubated at room temperature for 5 hours for complete enzymatic reaction. After formed, 
the cell-siRNAgels were cultured in the full culture media (10% FBS containing F-12K media) 
in a humidified incubator at 37 °C and 5% CO2 level. 
4.7.3 Characterization of X-siRNA and X- c1-siRNA building blocks  
Agarose gel electrophoresis  
The nusieve agrose gel electrophoresis was used to confirm the successful self-assembly of 
X-siRNA building blocks. The 5% nusieve agarose gels were ran in the running buffer consisting 
of 89 mM tris-HCl (pH 8.0), 89 mM boric acid, and 2 mM EDTA (TBE), and post-stained with 
1x gel red for 60 minutes. The samples were run in 1x sample orange loading dyes (NEB). The 
gels were run on a Bio-rad electrophoresis unit at 4 °C with constant voltage (5V/cm).  
Native polyacrylamide gel electrophoresis (PAGE)  
Acrylamide: Bisacrylamide (19:1) ratio was used to prepare native PAGE for characterizing 
X-c1-siRNA building blocks. The gels were composed of 9% (19:1) native PAGE and casted 
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with 1mm glass with the mini Bio-rad PAGE system. The gels were run in TBE buffer at 4 °C 
with constant voltage. The samples were run in 1x sample orange loading dyes (NEB). The gels 
were posted-stained with 1x gel red for 30 minutes and imaged by Kodak gel imaging system. 
4.7.4 Characterization of siRNA hydrogel and c1-siRNA hydrogel formation 
SiRNA and c1-siRNA encapsulation efficiency  
The siRNA and c1-siRNA hydrogels were formed as described in section 4.7.1 with 3’ FAM- 
conjugated antisense siRNA strands. After formed, the hydrogels were washed with PBS buffer 
twice at room temperature, 37 °C overnight and the supernatant was collected. The non-ligation 
X-siRNA and X-c1-siRNA in the supernatant was detected by measuring the fluorescence 
intensity using the synergy4 plate reader at 485/528 nm for excitation and emission wavelengths, 
respectively. The encapsulating efficiency was calculated as following.  
 
4.7.5 Chracterization of RNase H enzymatic reactions for siRNA time-specific and 
controlled release profiles 
RNase H treatment of X-siRNA and X-c1-siRNA building blocks  
The siRNA hydrogels were formed at 25:1 ratio (100:4 µM) and digested with 40 units of 
RNase H for time-specific profiles and 20, 0.5, and 0.125 unit of RNase H for different 
controlled release profiles. The reaction was incubated at 37 °C and all supernatant were 
collected at different time points. The collected supernatant was one hour and the RNAse H 
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digestion was characterized by 5% nusieve agarose gel electrophoresis following the section 
4.8.3. 
RNase H treatment of siRNA and aptamer-siRNA hydrogels  
The siRNA and aptamer-siRNA hydrogels (with FAM-conjugated antisense siRNA) were 
formed as previously described by using FAM- conjugated antisense siRNA. The non-ligated 
siRNA was washed out from the gels with PBS buffer. For time-specific triggering siRNA, 40 
units of RNase H enzymes were added in the siRNA hydrogels and incubate at 37 °C for 1 hour. 
Then, the supernatant was collected and the fluorescence intensity of FAM was determined. As 
for the siRNA controlled release study, the siRNA hydrogels were incubated with 0.125, 0.25, 
0.5, and 40 units of RNAse H  at 37 °C. At specific time points, the supernatant was transferred 
to new tubes and the fresh RNase H reaction mixtures were replaced. All the supernatant was 
measured by fluorescence using the synergy4 plate reader at 485/528 nm for excitation and 
emission wavelengths, respectively. The released FAM-conjugated siRNA were reported as 
cumulative release of siRNA relative to total encapsulated the siRNA in the hydrogels over 
releasing times.  
4.7.6 Cell culture and cell encapsulation  
Cell maintenance  
Human cervical adenocarcinoma cells (HeLa) were cultured in Dulbecco's Modification of 
Eagle's Medium (DMEM) supplemented with 10% FBS, 200 IU/mL penicillin, and 100 µg/mL 
streptomycin. The cells were sub-cultured in tissue culture- treated 25 cm3 flasks at 90% 
confluence and media were changed every other day.  
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Cell preparation for c1-siRNA hydrogel formation  
HeLa Cells were trypsinized and  centrifuged to pellet the cells at 1000 rpm for 5 minutes. 
The cells were re-suspended in 5uL Optimem-I serum-free media to desired density to get 
200,000 cells/ mL at final cell density in the gels.  
 4.7.7 Fluorescence confocal microscopic analysis 
Cell-encapsulating c1-siRNA hydrogels were washed twice with PBS buffer, fixed with 4% 
paraformaldehyde for 4 hours at room temperature, permeabilized with 1% Triton-X 100 
containing 1% BSA in PBS solution for 1 hour, stained with Alexa 488-conjugated phaloidin 
proteins. In between each step, the samples were washed twice with PBS buffer. The cell-
encapsulating hydrolgels were sealed with cover glass slip on a chamber slide and 20x or 40x oil 
immersion objective lens were used to capture 2d cell images using an upright Zeiss comfocal 
microscope. 
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Table 4.1 Oligonucleotide sequences of modified X-DNA building blocks and RNA for the siRNA-DNA hydrogels 
Strand 5’ palindromic 
segment 
Core segment 3’segment 
X1 Regular 5’-p-ACGT CGACCGATGAATAGCGGTCAGATCCGTACCTAC TCG-3’ 
X2 Regular 5’-p-ACGT  
CGAGTAGGTACGGATCTGCGTATTGCGAACGAC 
 
TCG-3’ 
X3 Regular 5’-p-ACGT  
CGAGTCGTTCGCAATACGGCTGTACGTATGGTC 
TCG-3’ 
Hybrid (12) 5’-p-ACGT TCGCGATTGACTCTC-3’ 
Hybrid (20) 5’-p-ACGT TCGTTTTTTTTTTTTTTTTTTTT-3’ 
X4 Regular 5’-p-ACGT CGAGACCATACGTACAGCACCGCTATTCATCGG TCG-3’ 
C1-scramble siRNA 
antisense template strands 
5’TAATACGACTCACTATAGGGTGCGAATCCTCTATCCGTTCTAAACGCTTTATGATTTCGCATTAGTACTGCT 
TACGATAC GGAAAAAAAAAAAAAAAAAAAAAA-3’ 
C1-scramble siRNA  
sense template strands 
5’-TTTTTTTTTTTTTTTTTTTTTTCCGTATCGTAAGCAGTACTAATGCGAAATCATAAAGCGTTTAGAACGGA 
TAGAGGATTCGCACCCTATAGTGAGTCGTATTA-3’ 
GAPDH antisense siRNA 5’-p-AAAGUUGUCAUGGAUGACCdTdT-3’ 
GAPDH sense siRNA 5’-p-GGUCAUCCAUGACAACUUU-3’ 
Scramble siRNA-FAM 5’-CCGUAUCGUAAGCAGUACUdTdT /36-FAM/-3’ 
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Note that 1.  p represents the phosphorylation on the 5’ end of the oligonucleotide. 
                 2. Regular represents the previously reported X-DNA sequences. 
                 3. Hybrid (12) and (20) represent the oligonucleotide sequence with extended (12 and/or 20) nucleotides for RNA/DNA     
hybridization 
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CHAPTER 5 
Conclusion and Future Outlook 
It has been shown that emerging DNA nanotechnology has been playing important roles in 
biomedical fields in a number of ways. Due to the precisely controlled properties of DNA, DNA 
nanotechnology has been seen in constructing numerous unique DNA nanostructures that can 
later self-assembly to more complex and larger DNA structures.  These DNA structures have 
been further employed in several biomedical applications. To give some examples, the highly 
accurate Watson-Crick base pairing rules of DNA have led them to be useful in target-specific 
detection systems where the DNA structures can complementarily hybridize to target genes even 
presenting in low copies. Moreover, the anisotropic property of DNA allows us to generate 
multifunctional DNA structures that can retain multi-functions in the only one DNA structure. 
Furthermore, the employment of molecular toolkits can add more advantages to DNA 
nanotechnology. A plethora of available recombinant enzymes can be used to modify, cut, 
extend, and decorate the DNA structures rendering a large room in tailoring the desire DNA 
structures to specific applications. 
The works discussed in this dissertation have further expanded the use of DNA 
nanotechnology in three biomedical applications. First, Y-shaped DNA-lipid amphiphile 
building blocks were synthesized and utilized to create a liposome-like structure called 
DNAsomes. The DNAsomes facilitate the co-delivery of hydrophobic drugs and siRNA giving 
synergistic therapeutic effects, thereby reducing the requirement of therapeutic thresholds for 
both drugs and siRNA. Also, the multifunctional property of DNA that was employed in 
fluorescent dye conjugation allows DNAsome to be tracked and imaged under a fluorescence 
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microscope. Despite of success in demonstrating the proof-of-concept of utilizing DNAsomes for 
2D in vitro systems, we, hence, aim at exploring the effects of the DNAsomes in in vivo models 
which will provide us more insights in developing the DNAsomes as a novel co-delivering 
platform for further clinical studies.  
Second, we expanded the use of synthetic branched DNA building blocks that self-assembled 
into the DNA hydrogels for 3D cell culture application. Cells that encapsulated inside the DNA 
hydrogels formed loose or tight MCS morphology depending on types and characteristics of 
individual cell lines. Also, the DNA hydrogels underwent natural degradation over time without 
physical or chemical disruption. Additionally, on-demand DNA hydrogel degradation is 
achieved by adding DNase I enzymes. Even though we do not demonstrate the specific use of 
our novel 3D cell culture DNA hydrogel platform, we here propose the use of the DNA 
hydrogels for cancer biology study in which MCS are required to subsequently recover from the 
hydrogels. Importantly, we take an advantage of a unique DNA hydrogel property that can 
undergo both natural and on-demand degradation without strong physical and/or chemical 
disruption to cells. Specifically, avascular tumor spheroids, which are an in vitro model of 
various metastatic cancer cell lines, are formed and proliferate inside the degradable DNA 
hydrogels. The avascular tumor spheroids can be retrieved from the DNA hydrogels as desired 
for drug resistant study, high-throughput drug screening, and the responsive effects of different 
microenvironments to cancer cells. However, using the DNA hydrogels might raise a concern 
regarding the fast degradation of the DNA hydrogels in vivo. Therefore, further investigation is 
required to obtain the insights of the DNA hydrogel susceptibility to in vivo conditions.  
Third, the concept of controlling siRNA releases has also proposed by taking advantages of 
innate siRNA-DNA hybridization and RNAse H-specific digestion of RNA/DNA hybrids. 
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Different controlled release siRNA profiles were obtained with prolonging siRNA from the DNA 
hydrogels. Last but not least, the two-in-one DNA hydrogels was purposed for 3D siRNA 
delivery. Although further characterization is required in this case, the success of the 3D siRNA 
delivery by the DNA hydrogels will be requiring less complexity and potentially sustaining the 
release of siRNA for a long period of times. 
Nevertheless, there are challenges waiting to be resolve before the full use of DNA 
nanotechnology can be achieved in biomedical fields. The main challenge of using DNA 
nanostructures in biomedicines is the susceptibility of DNA in vivo. Natural linear DNA is 
degraded after being injected in to a blood circulation in few minutes. However, recent efforts 
have improved the DNA stability by employing different modification such as 2’ fluoro-
modified nucleotides and phosphorothioate-modified DNA back bones resulting in reduced 
affinity of the DNA to nuclease enzymes. In fact, the use of the DNA nanostructures has been 
proved to partially resistant to the nucleases as the building blocks of DNA nanostructures are 
made of branched structures delaying degradation. Thus, the combination of modified and 
branched DNA building blocks might potentially prolong the stability of the DNA structures in 
vivo giving enough time for the DNA structures to complete their functions.  
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